<SEC-DOCUMENT>0001213900-21-054646.txt : 20211026
<SEC-HEADER>0001213900-21-054646.hdr.sgml : 20211026
<ACCEPTANCE-DATETIME>20211026163324
ACCESSION NUMBER:		0001213900-21-054646
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20211025
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211026
DATE AS OF CHANGE:		20211026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SG BLOCKS, INC.
		CENTRAL INDEX KEY:			0001023994
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
		IRS NUMBER:				954463937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38037
		FILM NUMBER:		211349015

	BUSINESS ADDRESS:	
		STREET 1:		195 MONTAGUE STREET, 14TH FLOOR
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11201
		BUSINESS PHONE:		(646) 240-4235

	MAIL ADDRESS:	
		STREET 1:		195 MONTAGUE STREET, 14TH FLOOR
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CDSI HOLDINGS INC
		DATE OF NAME CHANGE:	19990114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PC411 INC
		DATE OF NAME CHANGE:	19961001
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea149350-8k_sgblocks.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SGBX="http://sgblocks.com/20211025">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_SGBX_sgblocks.com_20211025 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20211025_20211025 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001023994 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityCentralIndexKey">0001023994</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sgbx-20211025.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-10-25to2021-10-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023994</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-25</xbrli:startDate>
        <xbrli:endDate>2021-10-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20211025__20211025_zg0S04xUNwW7"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):&#160;<b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20211025__20211025_zlSBeZ7OcrWh"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">October
25, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20211025__20211025_zWsillL1ehOf"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityRegistrantName">SG BLOCKS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20211025__20211025_zIaFkafKkNZg"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20211025__20211025_zKyrZ008H3Ha"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityFileNumber">001-38037</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20211025__20211025_zGQZdzsbYKA7"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityTaxIdentificationNumber">95-4463937</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction<br />
of Incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer<br />
Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20211025__20211025_zrDii6BCcjZ8"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityAddressAddressLine1">195 Montague Street</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20211025__20211025_zzoErDqzRt4l"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityAddressAddressLine2">14th Floor</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20211025__20211025_zye3sLupdy9a"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityAddressCityOrTown">Brooklyn</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20211025__20211025_zuQLyVX2lC35"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20211025__20211025_zi0BUFwfhXFb"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:EntityAddressPostalZipCode">11201</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of Principal Executive Offices, Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&#8217;s telephone number, including
area code: <span id="xdx_90B_edei--CityAreaCode_c20211025__20211025_zrd526TJFSQ"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:CityAreaCode">646</ix:nonNumeric></span>-<span id="xdx_909_edei--LocalPhoneNumber_c20211025__20211025_zGzsqTv1uHJ2"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:LocalPhoneNumber">240-4235</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--WrittenCommunications_c20211025__20211025_zhFXKOpZ1HOd"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--SolicitingMaterial_c20211025__20211025_zjVBAkjXcpw2"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20211025__20211025_zAKbZiFAhbOl"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20211025__20211025_zuiramO5E0k"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title
    of Each Class</b></span></td>
    <td style="width: 2%; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading
    Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of Each Exchange on Which Registered</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--Security12bTitle_c20211025__20211025_zjJyfJnubKM"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:Security12bTitle">Common Stock, par value $0.01</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--TradingSymbol_c20211025__20211025_zDN4yD1LzXbh"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" name="dei:TradingSymbol">SGBX</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>The <span id="xdx_904_edei--SecurityExchangeName_c20211025__20211025_zbz7jFPEnvS9"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#160;<span id="xdx_901_edei--EntityEmergingGrowthCompany_c20211025__20211025_zzWAdgPjCEX8"><ix:nonNumeric contextRef="From2021-10-25to2021-10-25" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
October 25, 2021 (the &#8220;Effective Date&#8221;), SG Blocks, Inc., a Delaware corporation (the &#8220;Company&#8221;) entered into
a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with an institutional investor (the &#8220;Purchaser&#8221;) for
the&#160;<span style="background-color: white">purpose of raising approximately $11.55 million in gross proceeds for the Company</span>.&#160;<span style="background-color: white">Pursuant
to the terms of the Purchase Agreement, the Company agreed to sell (A) in a registered direct offering</span>&#160;(i) 975,000 shares
(the &#8220;Public Shares&#8221;) of its Common Stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), and (ii) pre-funded
warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to 2,189,384 shares (the &#8220;Pre-Funded Warrant Shares&#8221;) of Common
Stock and (B) in a concurrent private placement, Series A warrants to purchase up to 1,898,630 shares (the &#8220;Common Stock Warrant
Shares&#8221;) of Common Stock (the &#8220;Common Stock Warrants,&#8221; and together with the Public Shares and the Pre-Funded Warrants,
the &#8220;Securities&#8221;) (the &#8220;Offering&#8221;). Each Public Share and accompanying Common Stock Warrant are being sold together
at a combined offering price of $3.65, and each Public Share and accompanying Pre-Funded Warrant are being sold together at a combined
offering price of $3.649. The Pre-Funded Warrants will be immediately exercisable at a nominal exercise price of $0.001 and may be exercised
at any time until all of the Pre-Funded Warrants are exercised in full. The Common Stock Warrants will have an exercise price of $4.80
per share, will be exercisable upon issuance and will expire five years from the date of issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
closing of the sales of the Securities pursuant to the Purchase Agreement is expected to occu<span style="background-color: white">r on
or about October 27, 2021, subject to customary closing conditions (the &#8220;Closing Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A.G.P./Alliance
Global Partners (the &#8220;Placement Agent&#8221;) is acting as the exclusive placement agent for the Company, on a &#8220;reasonable
best efforts&#8221; basis, in connection with the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to that certain Placement
Agency Agreement, dated as of October 25, 2021, by and between the Company and the Placement Agent (the &#8220;Placement Agency Agreement&#8221;),
the Placement Agent will be entitled to (i) a cash fee equal to seven percent (7.0%) of the gross proceeds from the placement of the Securities
sold by the Placement Agent in the Offering and (ii) a non-accountable expense allowance of one half of one percent (0.5%) of the gross
proceeds from the placement of the Securities sold by the Placement Agent in the Offering. The Company also agreed to reimburse the Placement
Agent&#8217;s expenses up to $50,000 upon closing the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">T<span style="background-color: white">he
net proceeds to the Company after deducting the Placement Agent&#8217;s fees and the Company&#8217;s estimated offering expenses&#160;</span>(including
the approximately $8.0 million of net proceeds from the issuance of Pre-Funded Warrants and the Common Stock Warrants to be issued in
the concurrent private placement)&#160;<span style="background-color: white">are expected to be approximately $10.5 million. The Company
intends to use the net proceeds from the Offering for working capital and for other general corporate purposes&#160;</span>including to
potentially acquire additional properties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the terms of the Purchase Agreement and subject to certain exceptions as set forth in the Purchase Agreement, for a period of 90 days
after the Closing Date, the Company may not, without the prior written consent of the Purchaser, (i) offer, pledge, sell, contract to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible
into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statement
with the Securities and Exchange Commission relating to the offering of any shares of capital stock of the Company or any securities convertible
into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering of debt securities of the
Company, other than entering into a line of credit with a traditional bank or (iv) enter into any swap or other arrangement that transfers
to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company, whether any such transaction
described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of shares of capital stock of the Company or such other
securities, in cash or otherwise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, pursuant to the terms of the Purchase Agreement, the Company agreed that for one year from the Closing Date that it will not
enter into any Variable Rate Transaction. &#8220;Variable Rate Transaction&#8221; means a transaction in which the Company (i)&#160;issues
or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional
shares of Common Stock either (A)&#160;at a conversion price, exercise price or exchange rate or other price that is based upon and/or
varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or
equity securities, or (B)&#160;with a conversion, exercise or exchange price that is subject to being reset at some future date after
the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related
to the business of the Company or the market for the Common Stock or (ii)&#160;enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the Purchase Agreement, the Company is required within 30 days of the closing of the Offering to file a registration statement providing
for the resale of the shares of Common Stock issued and issuable upon the exercise of the Common Stock Warrants. The Company is required
to use commercially reasonable efforts to cause such registration to become effective within 45 days of the closing of the Offering (or
60 days in the event of a full review by the Commission) and to keep such registration statement effective at all times until no investor
owns any Common Stock Warrants or Common Stock Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Public Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares (but not the Common Stock Warrants or the Common Stock Warrant
Shares) were offered and sold by the Company pursuant to an effective&#160;<span style="background-color: white">registration statement
on Form S-3 (File No. 333-</span>228882) <span style="background-color: white">and a related prospectus supplement, dated October 25,
2021, in connection the Offering to be filed with the Commission.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
foregoing description of the material terms of the Common Stock Warrants, the Pre-Funded Warrants, the Placement Agency Agreement
and the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the
Form of Common Stock Warrant, the Form of Pre-Funded Warrant, the Placement Agency Agreement and the Form of Purchase Agreement,
copies of which are filed as Exhibits 4.1, 4.2, 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The legal opinion and consent
of Gracin &amp; Marlow, LLP relating to the Public Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares are filed as Exhibits
5.1 and 23.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3.02. Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information contained
above in Item 1.01 related to the Common Stock Warrants and the Common Stock Warrant Shares is hereby incorporated by reference into this
Item 3.02. The Common Stock Warrants and the Common Stock Warrant Shares are being sold and issued without registration under the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemptions provided by Section 4(a)(2) of the Securities
Act as a transaction not involving a public offering and/or Rule 506 promulgated thereunder, and in reliance on similar exemptions under
applicable state laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 25, 2021, the Company
issued a press release announcing the Offering. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K
and is incorporated in this Item 8.01 by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The press release shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities in any state in which
the offer, solicitation or sale would be unlawful prior to the registration or qualification under applicable securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(d) Exhibits</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following exhibits are
being filed herewith:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit No.</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ea149350ex4-1_sgblocks.htm">Form of Series A Common Stock Warrant</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">4.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ea149350ex4-2_sgblocks.htm">Form of Pre-Funded Warrant</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">5.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ea149350ex5-1_sgblocks.htm">Opinion of Gracin &amp; Marlow, LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ea149350ex10-1_sgblocks.htm">Placement Agency Agreement, dated as of October 25, 2021, by and between the Company and the Placement Agent</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea149350ex10-2_sgblocks.htm"><span style="font: 10pt Times New Roman, Times, Serif">Form
    of Securities Purchase Agreement, dated as of October 25, 2021, by and between the Company and the Purchaser named
    therein</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">23.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ea149350ex5-1_sgblocks.htm">Consent of Gracin &amp; Marlow, LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="ea149350ex99-1_sgblocks.htm">Press Release of the Company, dated October 25, 2021</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">104</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">Cover
Page Interactive Data File (embedded within the XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font: 10pt Times New Roman, Times, Serif">SG Blocks, Inc.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Dated: October 26, 2021&#160;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Paul Galvin</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 5%"><span style="font: 10pt Times New Roman, Times, Serif">Name:&#160; </span></td>
    <td style="width: 31%"><span style="font: 10pt Times New Roman, Times, Serif">Paul Galvin</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Title: </span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Chairman and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">-4-</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwjAQRE/QOyz5Fk0KivRPi4pYRYqIv8FuJdhmyyateiRvaWwRl4VlmXkzQozEhtamQobLMs/ghHVTaY+QY4mM9orBkW53CYSb4804z9r6/v2BKQUGAzMdK6mD0Fs747BIQMlJPJvECqRK1BwWexF99ZRsaQq03ugKtC3gyNSwQa/5NSSc9JMs1a++6ozsDNkQN5aD/IZYqhgO1OkH8d1BlqUiGvUTiQ1T23xrWuephlWFdehyA/rf6AMLekk0 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea149350ex4-1_sgblocks.htm
<DESCRIPTION>FORM OF SERIES A COMMON STOCK WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEITHER THIS SECURITY NOR THE SECURITIES FOR
WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES A COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SG BLOCKS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 62%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant Shares: 1,898,630</FONT></TD>
    <TD STYLE="width: 38%; text-align: right; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Original Issue Date: October 27, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.15in; text-align: right">Initial Exercise Date: October 27, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">THIS SERIES A COMMON
STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received,
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and
subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the
&ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on October 27, 2026 (the
&ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from SG Blocks, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), up to 1,898,630 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the
Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><U>Section 1</U>. <U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if prices for the Common Stock are then reported on the OTCQB or OTCQX
and the OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share
of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Charter</U>&rdquo;
means the Company&rsquo;s Certificate of Incorporation, as amended, supplemented, restated or corrected, from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Securities Purchase Agreement, dated October 25, 2021, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Transfer
Agent</U>&rdquo; means American Stock Transfer and Trust Company, LLC, the current transfer agent of the Company, with a mailing address
of 6201 15<SUP>th</SUP> Avenue, Brooklyn, New York 11219 and a telephone number (800) 937-5449, and any successor transfer agent of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted on a Trading Market
and if prices for the Common Stock are then reported on the OTCQB or OTCQX and the OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common
Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open
Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent
appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to
the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the
cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in
which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $4.80, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">c) <U>Cashless
Exercise</U>. If at 60 days after the date hereof or any time thereafter at the time of exercise hereof there is no effective registration
statement registering, or the prospectus contained therein is not available for the resale of the Warrant Shares by the Holder, then this
Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall
be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A) =</FONT></TD>
    <TD STYLE="width: 80%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(B) =</FONT></TD>
    <TD STYLE="width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(X) =</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 93.15pt; text-align: justify; text-indent: -28.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being
issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants, and otherwise by physical delivery of a certificate (if such shares are certificated),
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise provided that payment of the aggregate
Exercise Price (other than in the instance of a cashless exercise) is received by the Company by such date, (ii) one (1) Trading Day after
delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period
after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;) provided
that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company by such date.
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after
such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain
a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">e)</FONT></TD>
    <TD STYLE="width: 97%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Holder&rsquo;s Exercise Limitations</U>. The
    Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant,
    pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable
    Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the
    Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess
    of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock
    beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable
    upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common
    Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
    or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
    securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
    exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
    Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
    with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
    the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
    is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
    Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
    with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
    Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
    (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
    Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
    or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
    in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
    2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
    Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
    a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
    the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
    confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
    shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
    Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
    Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock
    outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder,
    upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that
    the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after
    giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section
    2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP>&nbsp;day
    after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
    than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
    or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
    to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U STYLE="text-decoration: none">&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U STYLE="text-decoration: none"></U></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U STYLE="text-decoration: none">&nbsp;</U></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">f)</TD>
    <TD STYLE="text-align: justify; width: 97%; padding-bottom: 8pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"> Each certificate or notice of book entry evidencing Warrant Shares that are issued prior to the six- month anniversary of the Initial Issue Date at any time when there is no effective registration statement registering such Warrant Shares shall be imprinted with a legend in substantially the following form and consistent with the legends imprinted on certificates or book entries relating to other shares of Common Stock:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U STYLE="text-decoration: none">&nbsp;</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"></TD><TD STYLE="text-align: justify">THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
                                                                             AS AMENDED (THE &ldquo;<B>ACT</B>&rdquo;), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN THAT CERTAIN WARRANT TO
                                                                             PURCHASE STOCK ISSUED BY THE ISSUER TO ARMISTICE CAPITAL MASTER FUND LTD. DATED OCTOBER 27, 2021, MAY NOT BE OFFERED, SOLD, PLEDGED
                                                                             OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND
                                                                             SUBSTANCE SATISFACTORY TO THE ISSUER, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U STYLE="text-decoration: none">&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares
of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">b) <U>Intentionally
omitted</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if during such time as this Warrant is outstanding
the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro
rata to all of the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitations) immediately before the date on which a record
is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitations, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial or constructive
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">d) <U>Pro Rata
Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to all holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Ownership Limits) immediately
before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders
of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the
extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial or constructive
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series
of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another
Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities,
cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or
(v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock
(not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with
the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from
the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised
portion of this Warrant on the date of the consummation of such Fundamental Transaction;&nbsp;<U>provided</U>,<I>&nbsp;</I><U>however</U>,
if the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, Holder
shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction,
the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant,
that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that
consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to
receive from among alternative forms of consideration in connection with the Fundamental Transaction. &ldquo;<U>Black Scholes Value</U>&rdquo;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg,
L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes
and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of
the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100
day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day
immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such
calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration,
if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public announcement
of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a
remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the
Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available
funds within the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of
this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction or shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring
to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall
assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the
Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">g) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the
Company may satisfy this notice requirement in this Section 3(f) by filing such notice with the Commission pursuant to a Current Report
on Form 8-K or Quarterly or Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend or other distribution (other than a stock split), (B) the
Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the
granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or
of any rights (excluding any granting or issuance of rights to all of the Company&rsquo;s shareholders pursuant to a shareholder rights
plan), (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock
(other than a reverse stock split), any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially
all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or
property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the
Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number
or email address as it shall appear upon the Warrant Register of the Company, at least 4calendar days prior to the applicable record or
effective date hereinafter specified (unless such information is filed at least twenty calendar days prior to the applicable record with
the Commission on its EDGAR system in which case a notice shall not be required), a notice stating (x) the date on which a record is to
be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange
their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger,
sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall
not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this
Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise
this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.18 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 4.1 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">a) <U>No Rights
as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to
net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its Certificate
of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at SG Blocks, Inc., 195 Montague Street, 14<SUP>th</SUP> Floor, Brooklyn, NY 11201, Attention: Paul
Galvin, email address: pgalvin@sgblocks.com, or such other email address or address as the Company may specify for such purposes by notice
to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing
and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder
at the facsimile number, e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New
York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or
later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.
To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SG BLOCKS, INC.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Paul Galvin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TO: SG BLOCKS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">(1) The undersigned hereby
elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">(2) Payment shall take the
form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify"> &#9744; in lawful money of the
United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify"> &#9744; if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.35in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.9in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.35in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.35in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.35in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.35in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.35in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.35in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Investing Entity:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Investing Entity</I>: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 9.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 9.45pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: _______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 52%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 9.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">18</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea149350ex4-2_sgblocks.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Exhibit 4.2</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM OF</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>SG BLOCKS,
INC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Warrant Shares: 2,189,384</font></td>
    <td style="width: 50%; padding: 0.25pt; font-size: 10pt; text-align: right"><font style="font-size: 10pt">Original Issue Date: October 27, 2021</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: right">Initial Exercise Date: October 27, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] or its assigns
(the &#8220;<u>Holder</u>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &#8220;<u>Initial Exercise Date</u>&#8221;) and until this Warrant is exercised
in full (the &#8220;<u>Termination Date</u>&#8221;) but not thereafter, to subscribe for and purchase from SG Blocks, Inc., a Delaware
corporation (the &#8220;<u>Company</u>&#8221;), up to 2,189,384 shares (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;)
of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><u>Section 1</u>. <u>Definitions</u>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Affiliate</u>&#8221;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Bid Price</u>&#8221;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Business
Day</u>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Charter</u>&#8221;
means the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended, supplemented, restated or corrected, from time
to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Commission</u>&#8221;
means the United States Securities and Exchange Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Common
Stock</u>&#8221; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Common
Stock Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Exchange
Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Person</u>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><u>&#8220;Purchase
Agreement</u>&#8221; means the Securities Purchase Agreement, dated October 25, 2021, among the Company and the purchasers signatory thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Securities
Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Subsidiary</u>&#8221;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Trading
Day</u>&#8221; means a day on which the Common Stock is traded on a Trading Market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Trading
Market</u>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Transfer
Agent</u>&#8221; means American Stock Transfer and Trust Company, LLC, the current transfer agent of the Company, with a mailing address
of 6201 15<sup>th</sup>&nbsp;Avenue, Brooklyn, New York 11219, and its telephone number is (800) 937-5449, and any successor transfer
agent of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>VWAP</u>&#8221;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8220;<u>Warrants</u>&#8221;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><u>Section 2</u>. <u>Exercise</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <u>Exercise of
Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or
after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or
PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the
cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in
which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <b>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <u>Exercise Price</u>.
The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded to the Company
on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.001
per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not
be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any
reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid
exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <u>Cashless Exercise</u>.
This Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule 600(b)(68) of
Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the
principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221;
on such Trading Day;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <u>Mechanics
of Exercise</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <u>Delivery of
Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent
to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate
(if such shares are certificated), registered in the Company&#8217;s share register in the name of the Holder or its designee, for the
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice
of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise,
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company by
such date, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days
comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;<u>Warrant
Share Delivery Date</u>&#8221;) provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise)
is received by the Company by such date. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date
of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period
following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin
to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such
exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &#8220;<u>Standard Settlement Period</u>&#8221; means the standard settlement period, expressed in a
number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m.
(New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Purchase Agreement,
the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date
and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <u>Delivery
of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <u>Rescission
Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <u>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <u>No Fractional
Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <u>Charges,
Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>, <u>however</u>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <u>Closing
of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <u>Holder&#8217;s
Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall
be 9.99% (or, upon election by a Holder prior to the issuance of any Warrants, 4.99%) of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup>st</sup> day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><u>Section 3</u>. <u>Certain
Adjustments</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <u>Stock Dividends
and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding
shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of
capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares
of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <u>Intentionally
omitted</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <u>Subsequent
Rights Offerings</u>. In addition to any adjustments pursuant to Section 3(a) above, if during such time as this Warrant is outstanding
the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro
rata to the record holders of any class of shares of Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be
entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limits) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that
the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limits),
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial or constructive ownership of
such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in
abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limits)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <u>Pro Rata Distributions</u>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limits)) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, that, to the extent that
the Holder&#8217;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limits),
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial or constructive ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limits)).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">e)
<u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or
indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its
assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)
the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &#8220;<u>Fundamental Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor
Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the
consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction;&nbsp;<u>provided</u>,<i>&nbsp;</i><u>however</u>,
if the Fundamental Transaction is not within the Company&#8217;s control, including not approved by the Company&#8217;s Board of Directors, Holder
shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction,
the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant,
that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that
consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to
receive from among alternative forms of consideration in connection with the Fundamental Transaction. &#8220;<u>Black Scholes Value</u>&#8221;
means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg,
L.P. (&#8220;<u>Bloomberg</u>&#8221;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes
and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of
the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the 100
day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day
immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such
calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration,
if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public announcement
of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a
remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the
Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available
funds within the later of (i) five Business Days of the Holder&#8217;s election and (ii) the date of consummation of the Fundamental Transaction</font>.
<font style="font-size: 10pt">The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the
survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the obligations of the Company under this Warrant and
the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by
a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares
of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and
with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and
after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead
to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <u>Calculations</u>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <u>Notice to
Holder</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <u>Adjustment
to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however, that the
Company may satisfy this notice requirement in this Section 3(g)(i) by filing such notice with the Commission pursuant to a Current Report
on Form 8-K or Quarterly or Annual Report..</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <u>Notice to
Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend or any other distribution in whatever form on the Common Stock,
(B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock (other than in accordance with
Article VII of the Charter), (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights (excluding any granting or issuance of rights to all of the
Company&#8217;s shareholders pursuant to a shareholder rights plan), (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock (other than a reverse stock split), any consolidation or merger to which the
Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile
or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least
5 calendar days prior to the applicable record or effective date hereinafter specified (unless such information is filed at least five
calendar days prior to the applicable record with the Commission on its EDGAR system in which case a notice shall not be required), a
notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that
any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><u>Section 4</u>. <u>Transfer
of Warrant</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <u>Transferability</u>.
This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part,
upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute
and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <u>New Warrants</u>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <u>Warrant Register</u>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant Register</u>&#8221;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><u>Section 5</u>. <u>Miscellaneous</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <u>No Rights
as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section
2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to
net cash settle an exercise of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <u>Loss, Theft,
Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <u>Saturdays,
Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <u>Authorized
Shares</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its Charter
or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith
assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights
of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not
increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in
par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
Company to perform its obligations under this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <u>Governing
Law</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&#8217; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <u>Restrictions</u>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <u>Nonwaiver
and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <u>Notices</u>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier
service, addressed to the Company, at SG Blocks, Inc., 195 Montague Street, 14<sup>th</sup> Floor, Brooklyn, New York 11201, Attention:
Paul Galvin, email address: pgalvin@sgblocks.com, or such other email address or address as the Company may specify for such purposes
by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in
writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each
Holder at the facsimile number, e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication
or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New
York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or
later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.
To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <u>Limitation
of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <u>Remedies</u>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <u>Successors
and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <u>Amendment</u>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <u>Severability</u>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <u>Headings</u>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Signature Page Follows)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&nbsp;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&nbsp;</td>
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt; text-transform: uppercase"><b>SG BLOCKS, INC.</b></font></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; padding: 0.25pt">&nbsp;</td>
    <td style="width: 4%; padding: 0.25pt">&nbsp;</td>
    <td style="width: 36%; padding: 0.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">By:</font></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Name: Paul Galvin</font></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Title: Chief Executive Officer</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF EXERCISE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="text-transform: uppercase">To: SG
BLOCKS, INC.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">&#9744;</font>
in lawful money of the United States; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">&#9744;</font>
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="text-transform: uppercase">[SIGNATURE
OF HOLDER]</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 100%; font-size: 10pt"><font style="font-size: 10pt">Name of Investing Entity:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><font style="font-size: 10pt"><i>Signature of Authorized Signatory of Investing Entity</i>:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><font style="font-size: 10pt">Name of Authorized Signatory:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><font style="font-size: 10pt">Title of Authorized Signatory:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><font style="font-size: 10pt">Date:</font></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ASSIGNMENT FORM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><i>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Name:</font></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">(Please Print)</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Address:</font></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">(Please Print)</font></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Phone Number:</font></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt">&nbsp;</td>
    <td style="padding: 0.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="padding: 0.25pt; font-size: 10pt; text-align: justify"><font style="font-size: 10pt">Email Address:</font></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 15%; padding: 0.25pt 0.25pt 1.75pt">&nbsp;</td>
    <td style="width: 45%; padding: 0.25pt 0.25pt 1.75pt">&nbsp;</td>
    <td style="width: 40%; padding: 0.25pt 0.25pt 1.75pt">&nbsp;</td></tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: _______________ __, ______</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 15%; padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Holder&#8217;s Signature:</font></td>
    <td style="width: 35%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td>
    <td style="width: 50%; padding: 0.25pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt 0.25pt 1.75pt">&nbsp;</td>
    <td style="padding: 0.25pt 0.25pt 1.75pt">&nbsp;</td>
    <td style="padding: 0.25pt 0.25pt 1.75pt">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><font style="font-size: 10pt">Holder&#8217;s Address:</font></td>
    <td style="border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt">&nbsp;</td>
    <td style="padding: 0.25pt">&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">-16-</p>
<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea149350ex5-1_sgblocks.htm
<DESCRIPTION>OPINION OF GRACIN & MARLOW, LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex5-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Chrysler Building</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">405 Lexington Avenue, 26th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">New York, New York 10174</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Telephone (212) 907-6457</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U STYLE="text-decoration: none">www.gracinmarlow.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">October 25, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SG Blocks, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">195 Montague Street, 14th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brooklyn, New York 11201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">We
have acted as counsel to SG Blocks, Inc., a Delaware corporation (the &ldquo;</FONT><U>Company</U><FONT STYLE="background-color: white">&rdquo;),
in connection with a final prospectus supplement, dated October 25, 2021 (the &ldquo;</FONT><U>Prospectus Supplement</U><FONT STYLE="background-color: white">&rdquo;)
to the base prospectus (the &ldquo;<U>Base Prospectus</U>&rdquo;) that forms a part of the Registration Statement on Form S-3 (Registration
No. 333-228882) (the &ldquo;</FONT><U>Registration Statement</U><FONT STYLE="background-color: white">&rdquo;) filed by the Company under
the Securities Act of 1933, as amended (the &ldquo;<U>Securities&nbsp;</U></FONT><U>Act</U><FONT STYLE="background-color: white">&rdquo;),
with the U.S. Securities and Exchange Commission (the &ldquo;</FONT><U>Commission</U><FONT STYLE="background-color: white">&rdquo;), and
declared effective by the Commission on February 7, 2019,&nbsp;relating to the public offering of 975,000 shares (the &ldquo;</FONT><U>Shares</U><FONT STYLE="background-color: white">&rdquo;)
of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;</FONT><U>Common Stock</U><FONT STYLE="background-color: white">&rdquo;)
and pre-funded warrants (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;) to purchase up to 2,189,384 shares of Common Stock (the &ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo;).&nbsp;</FONT>The Base Prospectus and the Prospectus Supplement are collectively referred to as the &ldquo;<U>Prospectus</U>.&rdquo;&nbsp;<FONT STYLE="background-color: white">The
Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares are to be sold pursuant to a securities purchase agreement, dated as
of October 25, 2021, by and between the Company and the purchaser identified on the signature pages thereto (the &ldquo;</FONT><U>Purchase
Agreement</U><FONT STYLE="background-color: white">&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As counsel to the Company,
we have examined the Registration Statement, the Prospectus, the Purchase Agreement, the Pre-Funded Warrants and the originals or copies,
certified or otherwise identified to our satisfaction, of such other documents, corporate records, certificates of public officials and
other instruments as we have deemed necessary for the purposes of rendering this opinion and we are familiar with the proceedings taken
and proposed to be taken by the Company in connection with the authorization, issuance and sale of the Shares. In our examination, we
have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity with
the originals of all documents submitted to us as copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon and subject to
the foregoing, we are of the opinion that: (i) the Shares have been duly and validly authorized, and upon their issuance, delivery and
payment therefor in the manner contemplated by the Prospectus and Purchase Agreement, will be legally issued, fully paid and non-assessable,
(ii) the Pre-Funded Warrants have been duly and validly authorized, and upon their issuance, delivery and payment&nbsp;therefor in the
manner contemplated by the Prospectus and the Purchase Agreement, will be valid and binding obligations of the Company; and (iii) the
Pre-Funded Warrant Shares have been duly and validly authorized, and upon their issuance, delivery and payment therefor in the manner
contemplated by the Prospectus and the Pre-Funded Warrants, will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">SG Blocks,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">October 25, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We express no opinion as to
matters governed by any laws other than the General Corporation Law of the State of Delaware (including all related provisions of the
Delaware Constitution and all reported judicial decisions interpreting the General Corporation Law of the State of Delaware and the Delaware
Constitution), the State of New York and the federal laws of the United States of America, as in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the reference
to our firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus and to the filing of this opinion as Exhibit 5.1 to the Company&rsquo;s
Current Report on Form 8-K relating to the issuance and sale of the Shares pursuant to the Purchase Agreement. &nbsp;In giving our consent,
we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the
rules and regulations of the Commission thereunder. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Gracin &amp; Marlow, LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea149350ex10-1_sgblocks.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED AS OF OCTOBER 25, 2021, BY AND BETWEEN THE COMPANY AND THE PLACEMENT AGENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">October 25, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SG Blocks, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">195 Montague Street, 14<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brooklyn, NY 11201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: Paul Galvin</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chairman and Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear <FONT STYLE="background-color: white">Mr. Galvin</FONT>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter (the &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement between A.G.P./Alliance Global Partners, as lead placement agent (&ldquo;<B>A.G.P.</B>&rdquo; or the &ldquo;<B>Placement
Agent</B>&rdquo;), and SG Blocks, Inc., a company organized under the laws of the state of Delaware (the &ldquo;<B>Company</B>&rdquo;),
that the Placement Agent shall serve as the placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis, in connection
with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;) of (i) shares of common stock, par value, $0.01 per share (the &ldquo;<B>Shares</B>&rdquo;),
(ii) Series A warrants to purchase three-fifths of one share of common stock (&ldquo;<B>Warrants</B>&rdquo;) and (iii) Pre-Funded warrants
to purchase one share of common stock (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo; and together with the Warrants, the &ldquo;<B>Warrants</B>&rdquo;).
<FONT STYLE="background-color: white">The Warrants will be immediately exercisable and terminate five years following issuance and are
exercisable at an exercise price of $4.80 per share, subject to adjustment as set forth therein. The Pre-Funded Warrants will be immediately
exercisable</FONT> and will expire when exercised in full <FONT STYLE="background-color: white">and are exercisable at an exercise price
of $0.001 per share, subject to adjustment as set forth therein.</FONT> The Shares, Warrants and the shares of common stock issuable upon
exercise of the Warrants are collectively referred to as the &ldquo;<B>Securities</B>&rdquo;). The Securities actually placed by the Placement
Agent are referred to herein as the &ldquo;<B>Placement Agent Securities</B>.&rdquo; The Shares and the Pre-Funded Warrants shall be offered
and sold under the Company&rsquo;s registration statement on Form S-3 (File No. 333-228882) (the &ldquo;<B>Registration Statement</B>&rdquo;),
and the Warrants shall be offered and sold in reliance upon exemption from the registration requirements of Section 5 of the Securities
Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder. The documents executed and delivered by the Company and the Purchasers
(as defined below), as applicable, in connection with the Placement, including, without limitation, a securities purchase agreement (the
&ldquo;<B>Purchase Agreement</B>&rdquo;) and Warrant certificates, shall be collectively referred to herein as the &ldquo;<B>Transaction
Documents</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Shares, Pre-Funded Warrants
and Warrants shall be sold to the Purchasers for a purchase price of $3.65 per Share and Warrant or $3.649per Pre-Funded Warrant and Warrant.
The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the
Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of the Placement
shall be mutually agreed upon by the Company and the purchasers listed in the Purchase Agreement (each, a &ldquo;<B>Purchaser</B>&rdquo;
and collectively, the &ldquo;<B>Purchasers</B>&rdquo;), and nothing herein shall imply that the Placement Agent would have the power or
authority to bind the Company or any Purchaser, or shall imply that the Company has an obligation to issue any Securities or complete
the Placement. The Company expressly acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable
best efforts basis only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the
Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of the Placement Agent
with respect to securing any other financing on behalf of the Company. Certain affiliates of the Placement Agent may participate in the
Placement by purchasing some of the Placement Agent Securities. The sale of Placement Agent Securities to any Purchaser will be evidenced
by the Purchase Agreement between the Company and such Purchaser, in a form reasonably acceptable to the Company and the Purchaser. Capitalized
terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any
Purchase Agreement, officers of the Company will be available to answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 1</U>. <U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">A.
<U>Representations of the Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties and
covenants </FONT>(together with any related disclosure schedules thereto) <FONT STYLE="font-size: 10pt">made by the Company to the Purchasers
in the Purchase Agreement in connection with the Placement, is hereby incorporated herein by reference into this Agreement (as though
fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement
Agent. In addition to the foregoing, the Company represents and warrants that, to its knowledge, there are no affiliations with any FINRA
member firm participating in the Placement among the Company&rsquo;s officers, directors or, to the Company&rsquo;s knowledge, any five
percent (5.0%) or greater stockholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Covenants of the Company</U>.
The Company covenants and agrees to continue to retain (i) a firm of independent PCAOB registered public accountants for a period of at
least two (2) years after the Closing Date and (ii) a competent transfer agent with respect to the Placement Agent Securities for a period
of two (2) years after the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 2</U>. <U>REPRESENTATIONS
OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good standing of the Financial Industry
Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;), (ii) is registered as a broker/dealer under the Securities Exchange Act of 1934, as
amended (the &ldquo;<B>Exchange Act</B>&rdquo;), (iii) is licensed as a broker/dealer under the laws of the United States of America,
applicable to the offers and sales of the Placement Agent Securities by the Placement Agent, (iv) is and will be a corporate body validly
existing under the laws of its place of incorporation, and (v) has full power and authority to enter into and perform its obligations
under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in its status with respect to subsections
(i) through (v) above. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in
compliance with the provisions of this Agreement and the requirements of applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 3</U>. <U>COMPENSATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Cash Fees</U>. In consideration
of the services to be provided for hereunder, the Company shall pay to the Placement Agent or its respective designees a total cash fee
equal to seven percent (7.0%) of gross proceeds from the Placement of the total amount of Placement Agent Securities sold by the Placement
Agent. In addition, the Company shall pay the Placement Agent a non-accountable expense allowance of one-half percent (0.5%) of gross
proceeds from the Placement of the total amount of Placement Agent Securities sold by the Placement Agent. A.G.P. reserves the right to
reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA
to the effect that the Placement Agent&rsquo;s aggregate compensation is in excess of FINRA Rules or that the terms thereof require adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 4</U>. <U>EXPENSES</U>.
The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of its obligations hereunder
and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses incident to the issuance,
delivery and qualification of the Securities (including all printing and engraving costs); (ii) all fees and expenses of the registrar
and transfer agent of the Shares; (iii) all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of
the Placement Agent Securities; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified public accountants
and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution
of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Base Prospectus
and the Prospectus Supplement, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo;
fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining exemptions from the qualification
or registration of) all or any part of the Securities for offer and sale under the state securities or blue sky laws or the securities
laws of any other country; and (vii) the fees and expenses associated with including the Shares on the Trading Market. Notwithstanding
the foregoing, any advance received by the Placement Agent will be reimbursed to the Company to the extent not actually incurred in compliance
with FINRA Rule 5110(g)(4)(A). The Company&rsquo;s obligations to reimburse the Placement Agent for any out-of-pocket expenses actually
incurred including the fees and disbursements of A.G.P.&rsquo;s counsel, shall not exceed $50,000 in the aggregate. The Placement Agent
may deduct from the net proceeds of the offering payable to the Company on the Closing Date, the expenses set forth herein to be paid
by the Company to the Placement Agent. In the event that this Agreement shall not be carried out for any reason whatsoever, within the
time specified herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Placement Agent
their actual and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable and upon demand
the Company shall pay the full amount thereof to the Placement Agent; <I>provided</I>, <I>however</I>, that such expense payment in no
way limits or impairs the indemnification and contribution provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 5</U>. <U>INDEMNIFICATION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. To the extent permitted
by law, with respect to the Placement Agent Securities, the Company will indemnify the Placement Agent and its affiliates, stockholders,
directors, officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the reasonable
fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement, except to the extent
that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to
appeal) by a court of law to have resulted primarily and directly from the Placement Agent&rsquo;s willful misconduct or gross negligence
in performing the services described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. Promptly after receipt
by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which the Placement Agent
is entitled to indemnity hereunder, the Placement Agent will promptly notify the Company in writing of such claim or of the commencement
of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any obligation it may have hereunder,
except and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company
so elects or is requested by the Placement Agent, the Company will assume the defense of such action or proceeding and will employ counsel
reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding the preceding sentence,
the Placement Agent will be entitled to employ its own counsel separate from counsel for the Company and from any other party in such
action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable rules of professional
responsibility for the same counsel to represent both the Company and the Placement Agent. In such event, the reasonable fees and disbursements
of no more than one such separate counsel will be paid by the Company, in addition to fees of local counsel. The Company will have the
right to settle the claim or proceeding, provided that the Company will not settle any such claim, action or proceeding without the prior
written consent of the Placement Agent, which will not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. The Company agrees to notify
the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement of any action or proceeding
relating to a transaction contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. If for any reason the foregoing
indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless, then the Company shall contribute
to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or liabilities in such proportion as
is appropriate to reflect not only the relative benefits received by the Company on the one hand and the Placement Agent on the other,
but also the relative fault of the Company on the one hand and the Placement Agent on the other that resulted in such losses, claims,
damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses,
claims, damages and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending
any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the liable Placement Agent&rsquo;s share of
the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement Agent under
this Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement Agent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. These indemnification provisions
shall remain in full force and effect whether or not the transaction contemplated by this Agreement is completed and shall survive the
termination of this Agreement, and shall be in addition to any liability that the Company might otherwise have to any indemnified party
under this Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 6</U>. <U>COMPANY
LOCK-UP AGREEMENTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Restriction on Sales
of Capital Stock</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior written consent of the
Purchaser, which consent may be provided or withheld for any reason in Purchaser&rsquo;s sole discretion, it will not, for a period beginning
on the date of this Agreement and ending on the date that is the 90th day after the Closing Date (the &ldquo;<B>Lock-Up Period</B>&rdquo;),
(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of
the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or
cause to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company
or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering
of debt securities of the Company, other than entering into a line of credit with a traditional bank or (iv) enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company,
whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of shares of capital stock
of the Company or such other securities, in cash or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The restrictions contained
in this Section 6(a) (collectively, the &ldquo;<B>Restrictions</B>&rdquo;) shall not apply to (i) the Securities, (ii) the issuance by
the Company of securities of the Company pursuant to any documents, agreements or securities existing or outstanding as of the Closing
Date, provided that such existing or outstanding documents, agreements or securities have not been amended since the date of this Agreement
to increase the number of securities or to decrease the exercise price, exchange price or conversion price of securities (other than in
connection with stock splits or combinations or otherwise in accordance with their terms at the time of the Closing Date) or to extend
the term of such documents, agreements or securities, (iii) the issuance by the Company of any securities of the Company under any equity
compensation plan of the Company for services rendered to the Company; (iv) the issuance of shares of Common Stock issued by reason of
a dividend, stock split, split-up or other distribution on shares of Common Stock, (v) the issuance of shares of Common Stock or Common
Stock Equivalents issued to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt
financing, equipment leasing or real property leasing transaction, (vi) shares of Common Stock or Common Stock Equivalents issued to suppliers
or third party service providers in connection with the provision of goods or services or (vii) the issuance of any securities of the
Company in connection with a merger, joint venture, licensing arrangement or any other similar non-capital raising transaction or strategic
transaction, provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities, provided
that in each of (ii) through (iv) above, the securities shall be restricted from sale during the entire Lock-Up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Restriction on Continuous
Offerings</U>. Notwithstanding the restrictions contained in Section 6(a), the Company, on behalf of itself and any successor entity,
agrees that, it will not engage, for a period beginning on the date of this Agreement and ending on the date that is the 90th day after
the date of filing of the Registration Statement as set forth in Section 4.20 of the Purchase Agreement, directly or indirectly in any
&ldquo;at the market&rdquo; or continuous equity transaction, offer to sell, sell, contract to sell, grant any option to sell or otherwise
dispose of shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital
stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 7</U>. <U>ENGAGEMENT
TERM</U>. The Placement Agent&rsquo;s engagement hereunder will be until the earlier of (i) October 29, 2021 and (ii) the Closing Date.
The date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination Date</B>.&rdquo; In the event, however, in
the course of the Placement Agent&rsquo;s performance of due diligence it deems it necessary to terminate the engagement, the Placement
Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the
Termination Date but will remain responsible for fees pursuant to Section 3 hereof with respect to the Placement Agent Securities if sold
in the Placement and will remain responsible to reimburse expenses actually incurred and reimbursable pursuant to Section 4 hereof. Notwithstanding
anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation to pay any fees actually earned pursuant
to Section 3 hereof and any reimbursable expenses actually incurred and reimbursable pursuant to Section 4 hereof and the provisions concerning
confidentiality, indemnification and contribution contained herein will survive any expiration or termination of this Agreement. If this
Agreement is terminated prior to the completion of the Placement, all fees due to the Placement Agent as set forth in Section 3 and 4
shall be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees are earned or owed as of
the Termination Date). The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement
Agent by the Company for any purposes other than those contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 8</U>. <U>PLACEMENT
AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement
is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law, the Company
will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 9</U>. <U>NO FIDUCIARY
RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not
a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges and agrees that
the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to the equity
holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement Agent hereunder,
all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 10</U>. <U>CLOSING</U>.
The obligations of the Placement Agent, and the closing of the sale of the Placement Agent Securities hereunder are subject to the accuracy,
when made and on the Closing Date, of the representations and warranties on the part of the Company contained herein and in the Purchase
Agreement, to the performance by the Company of its obligations hereunder, and to each of the following additional terms and conditions,
except as otherwise disclosed to and acknowledged and waived by the Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. All corporate proceedings
and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Placement
Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby with respect to the
Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. The Placement Agent shall
have received from outside counsels to the Company such counsels&rsquo; written opinions with respect to the Placement Agent Securities,
addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. The Shares shall be registered
under the Exchange Act and listed on the Trading Market. The Company shall have taken no action designed to, or likely to have the effect
of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Shares from the
Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that the Commission
or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. No action shall have been
taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would,
as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially
and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any
federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale
of the Placement Agent Securities or materially and adversely affect or potentially and adversely affect the business or operations of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. The Company shall have
entered into a Purchase Agreement with each of the Purchasers of the Placement Agent Securities and such agreements shall be in full force
and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">F. FINRA shall have raised
no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested
by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any filing with the FINRA
Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all filing fees required in connection
therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">G. No stop order suspending
the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have
been initiated or threatened by the Commission; no order having the effect of ceasing or suspending the distribution of the Securities
or any other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock exchange
and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated by
any securities commission, securities regulatory authority or stock exchange; and all requests for additional information on the part
of the Commission shall have been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">H. Reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I. Officers&rsquo; Certificate.
The Placement Agent shall have received on each Closing Date a certificate of the Company, dated as of such Closing Date, signed by the
Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Placement Agent shall be satisfied that,
the signers of such certificate have reviewed the Registration Statement, the documents incorporated by reference therein (the &ldquo;Incorporated
Documents&rdquo;), any Prospectus Supplement, and this Agreement and to the further effect that:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) The representations and
warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date, and the Company has complied
with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to such Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) No stop order suspending
the effectiveness of the Registration Statement or the use of the Base Prospectus or any Prospectus Supplement has been issued and no
proceedings for that purpose have been instituted or are pending or, to the Company&rsquo;s knowledge, threatened under the Securities
Act; no order having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has
been issued by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for
that purpose have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities
regulatory authority or stock exchange in the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii) When the Registration
Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate, the Registration
Statement and the Incorporated Documents, if any, when such documents became effective or were filed with the Commission, and any Prospectus
Supplement, contained or incorporated by reference, all material information required to be included therein by the Securities Act and
the Exchange Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects
conformed to the requirements of the Securities Act and the Exchange Act and the applicable rules and regulations of the Commission thereunder,
as the case may be, and the Registration Statement and the Incorporated Documents, if any, and any Prospectus Supplement, did not and
do not include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading (provided, however, that the
preceding representations and warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance
upon and in conformity with information furnished in writing to the Company by the Placement Agent expressly for use therein) and, since
the effective date of the Registration Statement, there has occurred no event required by the Securities Act and the rules and regulations
of the Commission thereunder to be set forth in the Incorporated Documents which has not been so set forth; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) Subsequent to the respective
dates as of which information is given in the Registration Statement, the Incorporated Documents and any Prospectus Supplement, there
has not been: (a) any Material Adverse Effect; (b) any transaction that is material to the Company and the subsidiaries taken as a whole,
except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material to the
Company and the subsidiaries taken as a whole, incurred by the Company or any subsidiary, except obligations incurred in the ordinary
course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise of outstanding stock
options or warrants) or outstanding indebtedness of the Company or any subsidiary; (e) any dividend or distribution of any kind declared,
paid or made on the capital stock of the Company; or (f) any loss or damage (whether or not insured) to the property of the Company or
any subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">J. On or before each Closing
Date, the Placement Agent and counsel for the Placement Agent shall have received such information and documents as they may reasonably
require for the purposes of enabling them to pass upon the issuance and sale of the Securities as contemplated herein, or in order to
evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein
contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the conditions specified
in this Section 10 shall not have been fulfilled when and as required by this Agreement, all obligations of the Placement Agent hereunder
may be cancelled by the Placement Agent at, or at any time prior to, the Closing Date. Notice of such cancellation shall be given to the
Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 11</U>. <U>GOVERNING
LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements
made and to be performed entirely in such State, without regard to principles of conflicts of law. This Agreement may not be assigned
by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of
the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising
under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought
into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this
Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid
courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either
party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 12</U>. <U>ENTIRE
AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and supersedes
all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined to be
invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by the Placement Agent and the Company. The representations, warranties, agreements and covenants contained
herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities. This Agreement may be executed
in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature shall
create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such facsimile or .pdf signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 13</U>. <U>NOTICES</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address
specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day
after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on
a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following
the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 14</U>. <FONT STYLE="text-transform: uppercase"><U>Press
Announcements</U></FONT>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on its
website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">[<I>The remainder of this page
has been intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>A.G.P./ALLIANCE GLOBAL PARTNERS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 4%; padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>By: </B></FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/
    Thomas Higgins &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Address for notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">590 Madison Avenue 36<SUP>th</SUP> Floor</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10022</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Thomas Higgins</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: thiggins@allianceg.com</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Accepted and Agreed to as of the date first written above:&nbsp;</P></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SG BLOCKS, INC.</B>&nbsp;</P></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 4%; padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Paul Galvin</FONT></TD>
    <TD STYLE="width: 60%; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Paul Galvin</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><U>Address for notice</U>:</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">195 Montague Street, 14<SUP>th</SUP> Floor</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Brooklyn, NY 11201</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Attention: Paul Galvin</FONT></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chairman and Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: [*****]</P></TD>
    <TD STYLE="padding: 0.25pt"></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">-9-</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ea149350ex10-2_sgblocks.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT, DATED AS OF OCTOBER 25, 2021, BY AND BETWEEN THE COMPANY AND THE PURCHASER NAMED THEREIN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: center; text-indent: -0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of October 25, 2021, between SG Blocks, Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), as to the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant
Shares and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof
and/or Regulation D thereunder as to the Series A Warrants and the Series A Warrant Shares, the Company desires to issue and sell to
each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more
fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B><BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in">&ldquo;<U>Acquiring Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Applicable
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(ss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Buy-In
Price</U>&rdquo; shall have the meaning ascribed to such term in Section 4.18(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Code</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Common Stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Gracin &amp; Marlow, LLP, with offices located at The Chrysler Building, 405 Lexington Avenue, 26th Floor, New
York, New York 10174.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disqualification
Event</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1 (aaa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.20(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning ascribed to such term in Section 4.20(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>ERISA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>ERISA
Affiliate</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(rr).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, restricted stock units, options or other securities to employees,
officers, consultants or directors of the Company pursuant to any stock or option plan or arrangement duly adopted for such purpose,
by a majority of the non- employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose for services rendered to the Company, (b) equity or debt securities in connection with strategic transactions,
(c) shares of Common Stock issued by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock, (d)
shares of Common Stock or Common Stock Equivalents issued to banks, equipment lessors or other financial institutions, or to real property
lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction, (e) shares of Common Stock or Common Stock
Equivalents issued to suppliers or third party service providers in connection with the provision of goods or services, provided that
any securities issued pursuant to any of (b) through (e) of this definition are not registered pursuant to any registration statement
or prospectus and carry no registration rights that require or permit the filing of any registration statement or prospectus in connection
therewith during the Lock-Up Period provided for in Section 4.11 herein and (f) securities upon the exercise or exchange of or conversion
of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock
issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement
to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other
than in connection with stock splits or combinations or anti-dilution provisions contained therein and disclosed in the SEC Reports)
or to extend the term of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.20(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Governmental
Entity</U>&rdquo; means any governmental or regulatory agency, authority, body, entity or court, domestic or foreign, having jurisdiction
over the Company or its Subsidiaries or any of their assets or businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Issuer
Covered Person</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1 (aaa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.18(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Period</U>&rdquo; shall have the meaning assigned to such term in Section 4.11.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means A.G.P./Alliance Global Partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with
Section 2.2(a) hereof, which Pre-Funded Warrants shall be immediately exercisable and will expire when exercised in full, in the form
of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or, to the Company&rsquo;s knowledge, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Price</U>&rdquo; equals $3.65 per Share and accompanying Series A Warrant and $3.649 per Pre-Funded Warrant and accompanying Series A
Warrant, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the date of this Agreement. For the avoidance of doubt, the Purchase Price shall not be adjusted
for any payments of cash dividends by the Company to its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; shall have the meaning ascribed to such term in Section 4.20(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission File No. 333-228882 which registers the sale of the Shares,
the Pre-Funded Warrants and the Pre-Funded Warrant Shares to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Resale
Registration Statement</U>&rdquo; shall have the meaning ascribed to such term in Section 4.20(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Sarbanes
Oxley</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Warrants</U>&rdquo; means the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section
2.2(a) hereof, which Series A Warrants shall be immediately exercisable and have a term of exercise equal to five (5) years, in the form
of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Series
A Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Series A Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SMRH</U>&rdquo;
means Sheppard, Mullin, Richter &amp; Hampton LLP, with offices located at 30 Rockefeller Plaza, New York, New York 10112.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Standard
Settlement Period</U>&rdquo; shall have the meaning ascribed to such term in Section 4.18(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares, the Series A Warrants and the Pre-Funded Warrants
purchased hereunder based on the Purchase Price as specified below such Purchaser&rsquo;s name on the signature page of this Agreement
and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in immediately available funds (minus, if applicable,
a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants
are exercised).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, all exhibits and schedules thereto and hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means American Stock Transfer and Trust Company, LLC, the current transfer agent of the Company, with a mailing address
of 6201 15<SUP>th</SUP> Avenue, Brooklyn, New York 11219 and a telephone number (800) 937-5449, and any successor transfer agent of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if prices for the Common Stock are then reported on the OTCQB or OTCQX
and the OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share
of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.21.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Series A Warrants and Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the Series A Warrant Shares and the Pre-Funded Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B><BR>
PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $11,547,812.22 of Shares and Warrants. Notwithstanding anything herein to the contrary, in the
event that a Purchaser&rsquo;s Subscription Amount would cause such Purchaser&rsquo;s beneficial ownership to exceed 9.99% of the issued
and outstanding shares of Common Stock, in lieu of Shares in excess of such amount, such Purchaser shall be issued a Pre-Funded Warrant.
Each Purchaser&rsquo;s Subscription Amount (it being understood that on Closing, such amount shall be reduced by, if applicable, the
aggregate exercise price of the Pre-Funded Warrants issuable to such Purchaser) as set forth on the signature page hereto executed by
such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee. The Company
shall deliver to each Purchaser its respective Shares and a Warrant as determined pursuant to Section 2.2(a), and the Company and each
Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions
set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of SMRH or such other location as the parties shall mutually
agree. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo;
(&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and
addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt
of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor
shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, in the form and substance reasonably satisfactory to the Placement Agent and each of the Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
subject to the last sentence of Section 2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions,
on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
subject to the last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver, on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;),
equal to 975,000 Shares of Common Stock, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
a Series A Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 1,898,630 shares
of Common Stock, with an exercise price equal to $4.80, subject to adjustment therein (a copy of such executed Series A Warrant will
be delivered via email on the Closing Date and the originally executed Series A Warrant certificate may be delivered within two (2) Trading
Days of the Closing Date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 2,189,384
shares of Common Stock, with an exercise price of $0.001 per share, subject to adjustment therein; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount (less, if applicable, the aggregate exercise price of the Pre-Funded Warrants issuable to
such Purchaser hereunder), which as to the Shares shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the
Company or its designee and as to the Pre-Funded Warrants, will be wired to the account designated by the Company in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a
specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B><BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. Except as set
forth in <U>Schedule 3.1(a)</U>, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each
Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly
issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing (if a good standing concept exists in such jurisdiction) under the laws of the jurisdiction of
its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its
business as currently conducted. Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries
is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which
the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the
legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets,
business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material
adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such
jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals as set forth in Section 3.1(e) of this Agreement. This Agreement and each other
Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered
in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar
as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. Except as set forth on <U>Schedule 3.1(d)</U>, the execution, delivery and performance by the Company of this Agreement
and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the
transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or
any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict
with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s)
to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required
thereby, and (iv) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities
laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with
the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed
by the Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the
maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the
Registration Statement in conformity with the requirements of the Securities Act, which became effective on February 7, 2019 (the &ldquo;<U>Effective
Date</U>&rdquo;), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this
Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness
of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings
for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required
by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At the time the
Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration
Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and
did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time
the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material
respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company meets the
general eligibility requirements for the use of Form S-3 under the Securities Act and it meets the transaction requirements as set forth
in General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock and Common Stock Equivalents owned beneficially, and of record, by
Affiliates of the Company as of the date hereof. Other than as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital
stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options
under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee
stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most
recently filed periodic report under the Exchange Act. Except as set forth on <U>Schedule 3.1(g)</U>, no Person has any right of first
refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction
Documents. Except as set forth on <U>Schedule 3.1(g)</U> and as a result of the purchase and sale of the Securities, there are no outstanding
options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights
or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares
of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any
Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or
other securities to any Person (other than the Purchasers). Except as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding securities
or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of
such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in material compliance with all applicable federal and state securities laws, and none of such outstanding shares was issued
in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no stockholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
one (1) year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As
of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with United States generally accepted accounting principles (&ldquo;<U>GAAP</U>&rdquo;) applied on a consistent
basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. Except as
included therein, no historical or pro forma financial statements are required to be included in the Registration Statement, the Prospectus
or the Prospectus Supplement under the Securities Act or the Securities Act Regulations. The as adjusted financial information and the
related notes, if any, included in the Registration Statement, the Pricing Disclosure Package and the Prospectus have been properly compiled
and prepared in accordance with the applicable requirements of the Securities Act and the Securities Act Regulations and present fairly
the information shown therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are
appropriate to give effect to the transactions and circumstances referred to therein. All disclosures contained in the Registration Statement,
the Prospectus or the Prospectus Supplement regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules
and regulations of the Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities
Act, to the extent applicable. Each of the Registration Statement, the Prospectus and the Prospectus Supplement discloses all material
off-balance sheet transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company
with unconsolidated entities or other persons that may have a material current or future effect on the Company&rsquo;s financial condition,
changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components
of revenues or expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any material liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and any related losses and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant
to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company
has not purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not
issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company
does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities
contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1)
Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding,
arbitration, governmental proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the
Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency
or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;) which such Action,
(i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or
(ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor any current director or current officer thereof, is or has been the subject of any Action involving a
claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been,
and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company
or, to the Company&rsquo;s knowledge, any current or former director or officer of the Company. The Commission has not issued any stop
order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the
employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its
Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary,
and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries
believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company
or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in
favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable
U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of
employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including, without limitation, all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. To
the Company&rsquo;s knowledge, the costs and liabilities (including, without limitation, any capital or operating expenditures required
for clean-up, closure of properties or compliance with Environmental Laws, or any permit, license or approval, any related constraints
on operating activities and any potential liabilities to third parties) would not, singly or in the aggregate, have a Material Adverse
Effect on the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations, approval, licenses, clearances
and permits and orders and supplements and amendments thereto issued by the appropriate federal, state, local or foreign regulatory authorities
necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could
not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor
any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Property</U>. Except as set forth in <U>Schedule 3.1(o)</U>, the Company and its Subsidiaries have good and marketable title
in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal property which are material to the business
of the Company and its Subsidiaries taken as a whole, in each case free and clear of all liens, encumbrances, security interests, claims
and defects that do not, singly or in the aggregate, materially affect the value of such property and do not interfere with the use made
and proposed to be made of such property by the Company or its Subsidiaries; and all of the leases and subleases material to the business
of the Company and its Subsidiaries, considered as one enterprise, and under which the Company or any of its Subsidiaries holds properties
described or incorporated by reference in the Registration Statement, the Prospectus and the Prospectus Supplement, are in full force
and effect, and neither the Company nor any Subsidiary has received any notice of any material claim of any sort that has been asserted
by anyone adverse to the rights of the Company or any Subsidiary under any of the leases or subleases mentioned above, or affecting or
questioning the rights of the Company or any Subsidiary to the continued possession of the leased or subleased premises under any such
lease or sublease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. To the knowledge of the Company, the Company and the Subsidiaries have, or have rights to use, all patents,
patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses
and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses
as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual
Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any
of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement. except as would not reasonably be expected to have a Material Adverse Effect. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights
of any Person, except as could not have or would not reasonably be expected to have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the
Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of
the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other
than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company
and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended (&ldquo;<U>Sarbanes Oxley</U>&rdquo;) that are effective as of the date hereof,
and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and
as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have
evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The
Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except as set forth in the Prospectus Supplement, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this
Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company or any Subsidiary
to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth on <U>Schedule 3.1(w)</U>, the Company has not, in the twelve (12) months preceding the date hereof,
received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. Except as set forth on <U>Schedule 3.1(w)</U>, the
Company is in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer
through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to
the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer, except where
such nonpayment would not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Intentionally Omitted</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes material, non-public information which is not otherwise disclosed in the Prospectus
Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions
in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company
and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this
Agreement, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made,
not misleading. The press releases disseminated by the Company during the twelve (12) months preceding the date of this Agreement taken
as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
in order to make the statement therein, in the light of the circumstances under which they were made and when made, not misleading. The
Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the
Series A Warrants or Series A Warrant Shares under the Securities Act, or (ii) any applicable shareholder approval provisions of any
Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $250,000 (other than trade accounts payable and accrued expenses incurred in the ordinary course of business), (y) all guaranties,
endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected
in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments
for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments
in excess of $250,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is
in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, subject
to permitted extensions, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or
determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for
the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are
no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. The Company&rsquo;s independent registered accounting firm is set forth on <U>Schedule 3.1(dd)</U> of the Disclosure
Schedules. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by
the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual
Report for the fiscal year ending December 31, 2021. The Auditor has not, during the periods covered by the financial statements included
in the Registration Statement, the Prospectus and the Prospectus Supplement, provided to the Company any non-audit services, as such
term is used in Section 10A(g) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent in connection
with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Intentionally Omitted</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Money Laundering</U>. The operations of the Company and to the extent applicable to non US entities, its Subsidiaries, are and have
been conducted at all times in material compliance with applicable financial record-keeping and reporting requirements of the Currency
and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations
thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending
or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Regulations</U>. The disclosures contained in or incorporated by reference in the Registration Statement, the Prospectus and the Prospectus
Supplement concerning the effects of federal, state, local and all foreign laws, rules and regulations relating to this offering and
the Company&rsquo;s business as currently conducted or contemplated are correct and complete in all material respects and no other such
laws, rules or regulations are required to be disclosed in the Registration Statement, Prospectus and the Prospectus Supplement which
are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Dividends</U>. Since its most recently filed periodic report under the Exchange Act, except as set forth in <U>Schedule 3.1(oo)</U>,
the Company has not declared or paid any dividend or made any other distribution on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Related Party Transactions</U>. There are no business relationships or related party transactions involving the Company or any other
person required to be described in the Registration Statement, the Prospectus and the Prospectus Supplement that have not been described
as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Board of Directors</U>. The qualifications of the persons serving as board members and the overall composition of the board comply
with the Exchange Act, the Exchange Act Regulations, Sarbanes-Oxley and the rules promulgated thereunder applicable to the Company and
the listing rules of the Trading Market on which the Company&rsquo;s securities are currently listed. At least one (1) member of the
Audit Committee of the Board of Directors of the Company qualifies as an &ldquo;audit committee financial expert,&rdquo; as such term
is defined under Regulation S-K and the listing rules of the Trading Market on which the Company&rsquo;s securities are currently listed.
In addition, at least a majority of the persons serving on the Board of Directors qualify as &ldquo;independent,&rdquo; as defined under
the listing rules of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>ERISA Compliance</U>. The Company and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security
Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;<U>ERISA</U>&rdquo;)) established
or maintained by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all material respects with
ERISA. &ldquo;<U>ERISA Affiliate</U>&rdquo; means, with respect to the Company, any member of any group of organizations described in
Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations
thereunder (the &ldquo;<U>Code</U>&rdquo;) of which the Company is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA)
has occurred or is reasonably expected to occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained by
the Company or any of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of
its ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo;
(as defined under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material
liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo; or
(ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established or maintained by the Company
or any of its ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge
of the Company, nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Compliance with Laws</U>. Each of the Company and each Subsidiary: (A) is and at all times has been in compliance with all statutes,
rules, or regulations applicable to the business of the Company as currently conducted (&ldquo;<U>Applicable Laws</U>&rdquo;), except
as could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect; (B) has not received any
warning letter, untitled letter or other correspondence or notice from any Governmental Entity alleging or asserting noncompliance with
any Applicable Laws or any Material Permits; (C) possesses all material Permits and such Material Permits are valid and in full force
and effect and are not in material violation of any term of any such Material Permits; (D) has not received notice of any claim, action,
suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party alleging
that any activity conducted by the Company is in violation of any Applicable Laws or Material Permits and has no knowledge that any such
Governmental Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding;
(E) has not received notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or
revoke any Material Permits and has no knowledge that any such Governmental Entity is considering such action; and (F) has filed, obtained,
maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or
amendments as required by any Applicable Laws or Material Permits and that all such reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were corrected or supplemented
by a subsequent submission).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Contracts Affecting Capital</U>. There are no transactions, arrangements or other relationships between and/or among the Company,
any of its affiliates (as such term is defined in Rule 405 of the Securities Act) and any unconsolidated entity, including, but not limited
to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect the Company&rsquo;s
or its Subsidiaries&rsquo; liquidity or the availability of or requirements for their capital resources required to be described or incorporated
by reference in the Registration Statement, the Prospectus and the Prospectus Supplement which have not been described or incorporated
by reference as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
<U>Loans to Directors or Officers</U>. There are no outstanding loans, advances (except normal advances for business expenses in the
ordinary course of business) or guarantees or indebtedness by the Company or its Subsidiaries to or for the benefit of any of the officers
or directors of the Company, its Subsidiaries, or any of their respective family members, except as disclosed or incorporated by reference
in the Registration Statement, the Prospectus and the Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww)
<U>Dividends and Distributions</U>. Except as disclosed or incorporated by reference in the Registration Statement, the Prospectus and
the Prospectus Supplement, no Subsidiary of the Company is currently prohibited or restricted, directly or indirectly, from paying any
dividends to the Company, from making any other distribution on such Subsidiary&rsquo;s capital stock (to the extent that any such prohibition
or restriction on dividends and/or distributions would have a material effect to the Company), from repaying to the Company any loans
or advances to such Subsidiary from the Company or from transferring any of such Subsidiary&rsquo;s property or assets to the Company
or any other Subsidiary of the Company, except as may otherwise be provided in current loan or mortgage-related documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)
<U>Confidentiality and Non-Competitions</U>. To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the
Company or any Subsidiary is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement
with any employer (other than the Company) or prior employer that could materially affect his or her ability to be and act in his or
her respective capacity of the Company or such Subsidiary or be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Series A Warrants or the Series A Warrant Shares by the
Company to the Purchasers as contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Series
A Warrants or Series A Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Series
A Warrants or the Series A Warrant Shares for sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo; within
the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa)
<U>No Disqualification Events</U>. With respect to the Series A Warrants and the Series A Warrant Shares to be offered and sold hereunder
in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director,
executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act
(a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company
has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has
complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of
any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bbb)
<U>Other Covered Persons</U>. Other than the Placement Agent and The Benchmark Company, the Company is not aware of any person (other
than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in
connection with the sale of any Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ccc)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ddd)
Each financial or operational projection or other &ldquo;forward-looking statement&rdquo; (as defined by Section 27A of the Securities
Act or Section 21E of the Exchange Act) contained in the Registration Statement, the Prospectus or the Prospectus Supplement (i) was
so included by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions,
estimates and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements identifying those
factors that would reasonably be expected to cause actual results to differ materially from those in such forward-looking statement.
No such statement was made with the knowledge of an executive officer or director of the Company that is was false or misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(eee)
Nothing has come to the attention of the Company that has caused the Company to believe that the statistical or market-related data included
or incorporated by reference in the Registration Statement, the Prospectus or the Prospectus Supplement, or included in the marketing
materials, are not based on or derived from sources that the Company reasonably believes to be reliable and accurate, and the Company
has obtained the written consent to the use of such data from such sources, to the extent required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this
representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or
otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the
ordinary course of its business. Such Purchaser understands that the Series A Warrants and the Series A Warrant Shares are &ldquo;restricted
securities&rdquo; and have not been registered under the Securities Act or any applicable state securities law and is acquiring such
Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any
part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any
of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities
Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right to sell such Securities
pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3),
(a)(7) or (a)(8) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the
Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to
such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>General Solicitation</U>. Such Purchaser is not purchasing the Series A Warrants or the Series A Warrant Shares as a result of any
advertisement, article, notice or other communication regarding the Series A Warrants or the Series A Warrant Shares published in any
newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser,
any other general solicitation or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.9pt; text-align: justify; text-indent: 45.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B><BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Warrant Shares</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to
cover the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant
to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any
subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available
for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration
statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again
and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability
of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and state securities
laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance
or resale of the Warrant Shares effective during the term of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to timely
file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company
after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange
Act, except in connection with a merger or consolidation of the Company where the Company is not the surviving entity, or the acquisition
of, or any other going private transaction involving, the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the
Series A Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with Rule
144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy
the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes
an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information
Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash,
as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Series A Warrant
Shares, an amount in cash equal to two percent (2.0%) of the aggregate Exercise Price of such Purchaser&rsquo;s Series A Warrants on
the day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty
days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information
is no longer required for the Purchasers to transfer the Series A Warrant Shares pursuant to Rule 144. The payments to which a Purchaser
shall be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo;
Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information
Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public
Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing
herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall
have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the
transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the
Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other
in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall
issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any
press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which
consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party
shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the
Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission
or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities
law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any
material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that
such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers,
directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall
remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of
the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in
violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with
counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing,
(y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all
of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such
Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will
then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of
the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take
all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all material
respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company
agrees to use best efforts to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company
or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company
or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Lock-Up</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior written consent of the Purchaser,
which consent may be provided or withheld for any reason in Purchaser&rsquo;s sole discretion, it will not, for a period beginning on
the date of this Agreement and ending on the date that is the 90th day after the Closing Date (the &ldquo;<U>Lock-Up Period</U>&rdquo;),
(i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock
of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (ii) file
or cause to be filed any registration statement with the Commission relating to the offering of any shares of capital stock of the Company
or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii) complete any offering
of debt securities of the Company, other than entering into a line of credit with a traditional bank or (iv) enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company,
whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be settled by delivery of shares of capital stock
of the Company or such other securities, in cash or otherwise. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect
of an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Intentionally omitted</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Transaction Documents and the Disclosure Schedules. Notwithstanding the foregoing and notwithstanding anything contained in this
Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or
covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no
Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable
securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade
in the securities of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section
4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall
only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities
covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Sales During Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution
of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement
Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of any Shares to be issued hereunder to such Purchaser at
the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any
additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, and the Company shall
be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall
not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of
such Pre-Settlement Shares hereunder; and provided further that the Company hereby acknowledges and agrees that the forgoing shall not
constitute a representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall
sell any Shares to any Person and that any such decision to sell any Shares by such Purchaser shall solely be made at the time such Purchaser
elects to effect any such sale, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Sarbanes-Oxley</U>. The Company shall at all times comply with all applicable provisions of the Sarbanes-Oxley Act in effect from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Removal of Legends.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Series A Warrants and the Series A Warrant Shares may only be disposed of in compliance with state and federal securities laws. In
connection with any transfer of Series A Warrants or Series A Warrant Shares other than pursuant to an effective registration statement
or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.18(b), the
Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably
acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that
such transfer does not require registration of such transferred Series A Warrant or Series A Warrant Shares under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.18, of a legend on any of the Series A Warrants or the
Series A Warrant Shares in the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Series A Warrants or the Series A Warrant Shares to a financial institution
that is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) under the Securities Act and, if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured Series A Warrants or the Series A Warrant Shares to the pledgees or secured
parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee,
secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate
Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Series
A Warrants and the Series A Warrant Shares may reasonably request in connection with a pledge or transfer of the Series A Warrants or
the Series A Warrant Shares; provided that the pledged Series A Warrant Shares shall continue to reflect the legend set forth in this
Section 4.18(b) unless and until such legend can be removed in accordance with Section 4.18(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Series A Warrant Shares shall not contain any legend (including the legend set forth in Section 4.18(b) hereof):
(i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following any
sale of such Series A Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Series A Warrants), or (iii) if such Series
A Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Series A Warrants), or (iv) if such legend is
not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the
staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly
if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all
or any portion of a Series A Warrant is exercised at a time when there is an effective registration statement to cover the resale of
the Series A Warrant Shares, or if such Series A Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Series
A Warrants) or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission) then such Series A Warrant Shares shall be issued free of all legends. The
Company agrees that following such time as such legend is no longer required under this Section 4.18(c), the Company will, no later than
the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below)
following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Series A Warrant Shares, as
applicable, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered
to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make
any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section
4.18. Series A Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting
the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Series A Warrant
Shares issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Series A Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.18(c), $10 per Trading
Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the
Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause
to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such
Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion
of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A) such number of Series A Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Series A Warrant Shares (as the case may be) and ending
on the date of such delivery and payment under this Section 4.1(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.45pt; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares, the Pre-Funded Warrants, and the Pre-Funded Warrant Shares shall be issued free of legends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.45pt; text-align: justify; text-indent: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Form D; Blue Sky Filings</U>. If required by applicable law, the Company agrees to timely file a Form D with respect to the Series
A Warrants and Series A Warrant Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser.
The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to
qualify the Series A Warrant and Series A Warrant Shares for, sale to the Purchasers at the Closing under applicable securities or &ldquo;Blue
Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20
<U>Registration Statement.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Within
thirty (30) days of the Closing Date, the Company shall file (the &ldquo;<U>Filing Date</U>&rdquo;) a registration statement (the &ldquo;<U>Resale
Registration Statement</U>&rdquo;) providing for the resale by the Purchasers of the Series A Warrant Shares issued and issuable upon
exercise of the Series A Warrants (the &ldquo;<U>Registrable Securities</U>&rdquo;). The Company shall use commercially reasonable efforts
to cause such Resale Registration Statement to become effective within (i) in the event of no review by the Commission, forty-five (45)
calendar days, or (ii) in the event of a full review by the SEC, sixty (60) calendar days, both following the Closing Date (the &ldquo;<U>Effectiveness
Date</U>&rdquo;), and to keep such registration statement effective at all times until no Purchaser owns any Series A Warrants or Series
A Warrant Shares issuable upon exercise thereof (the &ldquo;Effectiveness Period&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) If:
(i) the Resale Registration Statement is not filed on or prior to its Filing Date (if the Company files the Resale Registration Statement
without affording the Holders the opportunity to review and comment on the same, the Company shall be deemed to have not satisfied this
clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of the Resale Registration Statement in
accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five (5) Trading Days of the date that
the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Resale Registration Statement will not
be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective date of the Resale Registration Statement,
the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of
such Resale Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that
such amendment is required in order for such Resale Registration Statement to be declared effective, or (iv) the Resale Registration
Statement registering for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date
of the Resale Registration Statement, or (v) after the effective date of the Resale Registration Statement and during the Effectiveness
Period, such Resale Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included
in such Resale Registration Statement, or the Holder is otherwise not permitted to utilize the Prospectus therein to resell such Registrable
Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not
be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such
five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded,
and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holder may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to the Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to this
Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date
payable, the Company will pay interest thereon at a rate of 12% per annum (or such lesser maximum amount that is permitted to be paid
by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such
interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis
for any portion of a month prior to the cure of an Event. Notwithstanding anything to the contrary herein, in no event shall the aggregate
amount of liquidated damages (excluding interest) payable to the Holder pursuant to this Section exceed, in the aggregate, 20.0% of the
aggregate purchase price paid by the Purchaser for the Securities issued at Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21 <U>Variable
Rate Transactions</U>. From the date hereof until the one (1) year following the Closing Date, the Company shall be prohibited from effecting
or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents
(or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i)&nbsp;issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for,
or include the right to receive additional shares of Common Stock either (A)&nbsp;at a conversion price, exercise price or exchange rate
or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after
the initial issuance of such debt or equity securities, or (B)&nbsp;with a conversion, exercise or exchange price that is subject to
being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii)&nbsp;enters into, or
effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities
at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance,
which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B><BR>
MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the
signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c)
the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document
constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchaser or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts
a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be
required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a
continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any
proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative
to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser.
Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of
the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision
hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for
a period of not longer than five (5) years from the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through SMRH. SMRH does not represent any of the Purchasers and only represents the Placement Agent. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company
and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SG BLOCKS,
    INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;195 Montague Street,
    14<SUP>th</SUP> Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%">&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Brooklyn,
    NY 11201</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Paul Galvin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
    pgalvin@sgblocks.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Chief Executive
    Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy
    to (which shall not constitute notice):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO SG BLOCKS SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile
Number of Authorized Signatory: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Warrants to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC
for Shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
A Warrant Shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrant Shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X&nbsp;]
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea149350ex99-1_sgblocks.htm
<DESCRIPTION>PRESS RELEASE OF THE COMPANY, DATED OCTOBER 25, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SG Blocks Announces $11.55 Million Registered
Direct Offering Priced At-The-Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Under Nasdaq Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEW YORK, October 25, 2021</B> -- SG Blocks,
Inc. (NASDAQ: SGBX) (&ldquo;SG Blocks&rdquo; or the &ldquo;Company&rdquo;), a leading designer, innovator and fabricator of modular structures,
announced today it has entered into a securities purchase agreement with a single U.S. institutional investor for the purchase and sale
of 3,164,384 shares of its common stock (or common stock equivalents in lieu thereof in the form of pre-funded warrants) together with
warrants to purchase up to 1,898,630 shares of common stock for gross proceeds of approximately $11.55 million. Each share of common stock
and accompanying common warrant are being sold together at a combined offering price of $3.65, and each common stock equivalent and accompanying
common warrant are being sold together at a combined offering price of $3.649. The common stock equivalents will be immediately exercisable
at a nominal exercise price of $0.001 and will expire when exercised in full. The common warrants will have an exercise price of $4.80
per share, will be exercisable upon issuance and will expire five years from the date of an issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering is expected to close on or about
October 27, 2021, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A.G.P./Alliance Global Partners is acting as sole
placement agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This offering is being made pursuant to an effective
shelf registration statement on Form S-3 (File No. 333-228882) previously filed with the U.S. Securities and Exchange Commission (the
&ldquo;SEC&rdquo;). A prospectus supplement describing the terms of the proposed offering will be filed with the SEC and will be available
on the SEC&rsquo;s website located at http://www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available,
from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email
at prospectus@allianceg.com. Before investing in this offering, interested parties should read in their entirety the prospectus supplement
and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in
such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release does not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation,
or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About SG Blocks, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">SG Blocks, Inc. is a
premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction.
The firm offers a product that exceeds many standard building code requirements, and also supports developers, architects, builders and
owners in achieving greener construction, faster execution, and stronger buildings of higher value. Each project starts with GreenSteel&trade;,
the structural core and shell of an SG Blocks building, and then customized to client specifications. For more information, visit www.sgblocks.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Safe Harbor Statement </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain statements in this press release constitute
&ldquo;forward-looking statements&rdquo; within the meaning of the federal securities laws. Words such as &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo;
&ldquo;predict,&rdquo; &ldquo;forecast,&rdquo; &ldquo;project,&rdquo; &ldquo;plan,&rdquo; &ldquo;intend&rdquo; or similar expressions, or statements
regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current
estimates and assumptions and include statements regarding the expected closing of the offering. While SG Blocks believes these forward-looking
statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information
available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of
which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those
set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current
expectations include, among others, the Company&rsquo;s ability to consummate the transactions described herein, the Company&rsquo;s ability
to expand within various verticals as planned, the Company&rsquo;s ability working as a team to meet its goals, the Company&rsquo;s ability
to position itself for future profitability, the Company&rsquo;s ability to maintain compliance with the Nasdaq listing requirements,
and the other factors discussed in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2020 and its subsequent
filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as
of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account
of new information, future events, or otherwise, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Contacts </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investors: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Stephen Swett</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(203) 682-8377</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">investors@sgblocks.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !W 8,# 2(  A$! Q$!_\0
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MFOC:%!?O)'H%'%>-R>*?$FJS>5#<S%CTCMDQ_+FDGF\5Z4HN;B74(4S]]V)
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MD.EA+R^"S7Q&0.JQ?3U/O775SXG,+>Y1^_\ R.K!Y2G^\Q&OE_F4M/TNRTN
M0V5ND2#T')^I[U!XA2-_#U^)5!3R&//TK4Z5B^+7*>%M0(_YY$?G7FTVY5%=
MZW/7K1C"A)):),\Q\&7L-AXC@GN)5BA".'=C@8Q_CBNIU'QK=ZK=KIGAR%FE
MDX^T,.GN!V'N:X73-+O-8NUMK*$R-_$W\*#U)KUWPYX;M?#]J53]Y<N/WLQ'
M)]AZ"O8QSH0GSRUET7ZL^=RI8FI3]E'W87U?7T0[0-!CT:W9I':>]F.Z>X?D
MN?3Z5M4=Z*\24G)W9]/3A&G%1CL+1112+"BBB@ HHHH **** "BBB@ HHHH
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***K7E[;6%LUQ=SQP0IR7D;
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M&6#I\M.[ZA1117(=85B:EH)N=3BU6PNFLM1C3RC(%#+*F<[74]>>0>HK;HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *MYI]GJ
M$7E7EK#<(?X94##]:YV;X;>$IW+-H\2D_P!QV4?D#115QJ3C\+9#A&7Q(M6/
M@7PSIT@DM]'M]XZ-(-Y'_?6:Z!55%"JH '0 444I2E+XG<(QC'X58=1114EA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
I%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>sgbx-20211025_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>sgbx-20211025_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sgblocks.com/role/Cover" xlink:href="sgbx-20211025.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sgblocks.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>sgbx-20211025.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWa2FiaPtyJ1xaYkxuG95fekKXyoi+KU9OyHWH0hWQYEB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:SGBX="http://sgblocks.com/20211025" elementFormDefault="qualified" targetNamespace="http://sgblocks.com/20211025">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sgblocks.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="sgbx-20211025_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="sgbx-20211025_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>ea149350-8k_sgblocks_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgbx-20211025.xsd" xlink:type="simple"/>
    <context id="From2021-10-25to2021-10-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023994</identifier>
        </entity>
        <period>
            <startDate>2021-10-25</startDate>
            <endDate>2021-10-25</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-10-25to2021-10-25">0001023994</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-10-25to2021-10-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-10-25to2021-10-25">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-10-25to2021-10-25">2021-10-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-10-25to2021-10-25">SG BLOCKS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-10-25to2021-10-25">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-10-25to2021-10-25">001-38037</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-10-25to2021-10-25">95-4463937</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-10-25to2021-10-25">195 Montague Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-10-25to2021-10-25">14th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-10-25to2021-10-25">Brooklyn</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-10-25to2021-10-25">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-10-25to2021-10-25">11201</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-10-25to2021-10-25">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-10-25to2021-10-25">240-4235</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-10-25to2021-10-25">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-10-25to2021-10-25">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-10-25to2021-10-25">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-10-25to2021-10-25">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-10-25to2021-10-25">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-10-25to2021-10-25">SGBX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-10-25to2021-10-25">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-10-25to2021-10-25">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140004821065512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 25,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SG BLOCKS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001023994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4463937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">195 Montague Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">14th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brooklyn<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">240-4235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGBX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ *H1:4Y>*NQS     $P(
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M_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ *H1:4R0>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( "J$6E-ED'F2&0$
M ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@
MIAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1
M?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI
M>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UP
MZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T
M,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^
MD<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#
M%     @ *H1:4P=!36*!    L0   !               ( !     &1O8U!R
M;W!S+V%P<"YX;6Q02P$"% ,4    "  JA%I3[75TH^X    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  JA%I3
MF5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( "J$6E,[1-=Y0 0  ,(0   8              "
M@0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  JA%I3
MGZ ;\+$"  #B#   #0              @ &##   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( "J$6E.7BKL<P    !,"   +              "  5\/  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( "J$6E.JQ"(6,P$  "("   /
M      "  4@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  JA%I3)!Z;
MHJT   #X 0  &@              @ &H$0  >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  JA%I399!YDAD!  #/ P  $P
M    @ &-$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #7
%$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea149350-8k_sgblocks.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sgblocks.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea149350-8k_sgblocks.htm">ea149350-8k_sgblocks.htm</File>
    <File>ea149350ex10-1_sgblocks.htm</File>
    <File>ea149350ex10-2_sgblocks.htm</File>
    <File>ea149350ex4-1_sgblocks.htm</File>
    <File>ea149350ex4-2_sgblocks.htm</File>
    <File>ea149350ex5-1_sgblocks.htm</File>
    <File>ea149350ex99-1_sgblocks.htm</File>
    <File>sgbx-20211025.xsd</File>
    <File>sgbx-20211025_lab.xml</File>
    <File>sgbx-20211025_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea149350-8k_sgblocks.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea149350-8k_sgblocks.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgbx-20211025_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgbx-20211025_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sgbx-20211025.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SGBX",
   "nsuri": "http://sgblocks.com/20211025",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea149350-8k_sgblocks.htm",
      "contextRef": "From2021-10-25to2021-10-25",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://sgblocks.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea149350-8k_sgblocks.htm",
      "contextRef": "From2021-10-25to2021-10-25",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://sgblocks.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001213900-21-054646-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-21-054646-xbrl.zip
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M'FQ1?X"I'LUG)N]8CB@]%M'M8DUE@"9"V_"T5*]4V!HN='.'(MRJ,4P#VS/
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M^:WBZDHH"[+A<N-+' Y0N/HH!@VQ&]2*WPY =('+ :/CF7L0M^!A$NRFO$M
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MQ@+*T7:0$:,X@;C1E\2,ZZ BB$ENHM-3PB#30K& 1JUTO;, 3T"U<[;5MT0
M(4L9+H&6I$E)IIC'9?0M[K<17\8YCTA=[0E'047Y2MK2/X;08SWXAV2[A6?!
M*&9B$O.#$*T(UUN1V426+(SFP 3DJ6DS7#)9YTC!,T64P'B:S<.$6[KLD-$N
M=-Z(]\+TI\BD*';O3).Y"ILEP[>Q)1):T,RG(X6>(8)&49I%)5@HF$'^ '%\
M8H$D10P4'#RL'I*8J];FPMP:2KH-B649$Q$7O:/_2?ED*B8%JHD81OJNZ[(J
M@5US/DB!+D)_!!UR% P9$"V*'+?CAD5#H!)'CE"'Z3%(V+O40@-1 ?&')>=)
M-2>*1K*S:PMF5I.H>I,U)75GQXS3%,!$<<PZ&X$T%N$#R6KQ[(CBG+C5B))=
M4=1C8LRSXC5X)RS>KM7.5=B:N!W6S;-*I9*30=YR>6MKJ[S.Y@QE8WV*4IDH
M>E#G!D-4_H.!G<CEQ;)XJRLBC9?,H$Z*N3#^%%I'$3_^R:L_@@O01^RZB%41
M>AG$[T4++X))^";I%5HS2ZY2<D+QK"JX1(K#IH/9I@L80=:BG(,G[<5XP T5
M$L.T:N++ 9A\\#B8/#JJ$OD=/>5HD3"G+^:I>!Q1_:3.DPO(1K?.I::+'EI?
M*$#"(:;5/YZ@'\@ H?"7-"\,L.)!H9ZEX[*J>6",:KZ<!8+)B^HI^ -^@OP8
M"#F P61:)Z"E*3-2\E,FBKVW<L<"<>&-U:B%T18$[,41]@)ZY$53HK!)-N\"
MN<-F.);PQ%26@D[>O_/PX#O[M]8?[."Y.ML=9=G)R?E4]'IINB65#E97:G+W
MRQ6DB(5V'T>.4P![<0(H5S&&]\(R-"K>K^2+Y3S[[,1JDMNJ'*TE'*HHK['<
MROW75RU SG?XD6IRF#51.BJ#\ X+3SR$*C^J%4@QB>Y+LBOJ!RJ6+FJ"4A-"
MG4)82/"K*[%MFUWZ.<^\$U6SRNV1Y@9F,Q,F5-HMB*LKL;.B6>1>K2_.L,6+
MC9)'2Z/*<HL28I:(<81>5E\F<,/3:OHX/*167=/6U\IA-<XD(-ID+ &5*K@;
MKGU#)4&@8$EBN;$BH8(ZP5HK;N"<_:'=%?N*FQ(&(\Q):'VK;]F:%X>8&@.M
M@-UG&>35D=G);&VT?&\EHMWRLVF42&QLT9D?\:F(%@63GD$VO#95>N:D%.;%
MW!@\D"TB"GAVPL=H@,U%;MX!P6],%6*Q!LB<09B(3'8",3&I(UF]#BKR854H
MK$^Z0C@F8"@   _##7U1L^CYJ'BV\$\BW.]I*H^ YA$=>Z)2>A(?X;$>%8\6
M5TMJRK.(M].'8+$X(N..5CE*%JIYPNQP/"X5"4H\Q8)O28"H!(.(#\N:D>2$
MGAAHY [1F\83!2!UP >0U2A2224$.L75R:4PXA(^+KXB>)8KPY:^T?-E8BM_
MDJXJZ5K^AR9=GX+RI$ZLDTX\# _AMU7,2=4#";_FE1]_Q5LD]O!#K0K>W8+U
MBL%]I(2/[KGG*MP 9C ><J Z4=*O*)W1 GZ6^^]?XRUS<WU],44VRNGK;V89
MCPO?8Z3LG5,W_^"-2Q*#D?@1_K;"S9M'??'NGE46E[_,@R@XN>!'XI9P;]JO
MKJ.:+Z7NS]S77OTR(C76\_#.&ZZ5JO5*K<AOJ[G2E=_5Z61]OA?T,WLJ3AD>
M!4[SE'<+VK(VX8L([CPQYLNO$//E&9B?#@<N$=W/3/.U5TCSM2F:/Y,!WWMB
MO+\9Q6."X-4AOE2<POSLQ,GRS_G]OER$69YE[6;JMDR*H@7A1 D67H)Z[^TJ
MR]A==6"$+F,SQ;R!2&.$R-)^"V[%/,ZKX]9I,=F,3NS,3(7) WHBBJ:L4] "
MZ[\O]V$L<?[=6>(.U.O3\I("<1<R$#=YN&*JFH*XZ:545ZE8?3)\W9,F;+HW
MF&R@X,@11HNT\#XI37ST>(WW=6Z:47T=(O'K_L4),UUC2&<VG_N>U/O#<]4_
MX3D5GJO\8\-S2[ZM;K&O"+>/WITV+C]?M-I/F-5:]@=0%[PDYWSBA(8L6:7
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M<?,X&BZAK!7V615SU=>66P4FJ@I8*#[;_QSQ89_FK2:BKC5PFC&"2K.'RQS
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M6^_.H^'KBV/*$KE\F!X5R@3%&"MAWGETB6D89 &0$@'1)7HX7/Z,7VG056L
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MU+0"%F)/11H>+/%0> 5&O$JNMJY&VO2&@_7)^,<TT2?>51$=8=&],68T40;
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M::]2 WOBDMI&&OM,EE_-@<03 3KUC'PM>5#<0Q#N"VR:IS/C&S?<3$A\N_0
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M&>R(9/U\J,('7:+!FFJ)[8M,.?'0L#U['#'$S* _MHRXK:<(&J%^JM%;D?Z
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M=WNO1N_+M-SK)Y-PGXO;2\+WIZ=O[BPO<[FS$K#[<N 1!X KCM#B#9P) <4
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MSOH@C)2';!=[B_*^3,L=CTF=,ZW%6U1"GG=]!ZE17KU'AR?[KCGW9EI6,D:
MLM9X2BOJ[9A?F6*]+;NY)PF^Q]/J2\)TL@%%>AMY4/Z1&QE*]O+Q*50:[)_?
MY:B_??;OT[?O7C[_\6PZ>?D2WLHS^.@MC/W-SV^?_W"*8?Y7+Z+STQ_/[MO,
M_HKW\5?)ULGA,8S]YW]+U0%NS</H=1E4(KP@#Y=0W/@QGM$2\W:D;A3>K,!4
M9#O;9;4Q HZXNK!"'2[58*ACP#4?P !M>P2XZR&F1(U&8ON&V7*0/0XSZW@Q
MY6W /BY<F8ZSA['A(WI8.!S"J("'0SV20 .! X>_QY\KC 87@-- 'EP$AO;?
MQ\?QXT=?Q5\?GQR>G. GGJ*R9U;TJFIQHIXYO89)P3]X?;PE!%^J7FN5!2S*
M%46,*48P ET9@<]$UU579.!Z=(W9!.&9F](L\A2YTJMK:4!%&*4/Z#I%3PZ?
M//D?=0L8L<T^K>\1C(-C:>1%;CIO*?*2;MS0Q4S'SD"?WO"\@A5&B2<C:OYP
M.CE+1B<UMA:S'%&_.%Q"0#4M>DA,_%>J@,?^F-P8:I-U*3E??101OYE/0 T%
MF/=P[@<#,,@(O$HR2[Q1:&A";S^RA,L$X2 .%07NJ9S(+W1G_0<6I&N41-;:
MZ@[CJ'O3;BO$E% 9$W4U-(?DILN7VJ5=-NX(K!]_"O*P$J(S;Z,DCDPR<'S]
M0H"P2Y#;TG;+H[L)#X03IK<:=D1P-?OE>6N6_G)[:$RXO?Z :Z1"=NWH9]2#
M3=+FS8+]''W?:05;U5JN3AG"NHP\IZ$'X94GAP_C0-_RH(68DI^NJ&/<4S^]
M_2'2P _/A@'LJ#>;0#'RC98=]E OUJ+48 9E07L1?WN-8LL@(1>PM&W!(DI^
MQ;Y(!$QRP5"O\N1V$C:=S)QM^.(_?G3U #;LH3F,5?[#(\A_V_QDTA/^@)3[
MCN,AH<8714'X17I)L"*<6[.5FX6A(*.L@TWJT3+(,A5K5=98G@<:8]8<Z&OJ
M+5R$E)ZM("K7O=WPE$]4C#B!RJ(($+U2'_+9OQ]/&HM*5S@.BOS450EJ"4\Q
M%7/O-G:H5GGY"%2<LS"1<M8:A%1WL6J0<9&@2!QNYQ16K,8WM,CKY0%>?8W]
MMFSB, P._46$<#MAD7_D7&[S/,PIAD/>DEK\<I]:E-3BE__,U.)?((Z?X3[Z
M Y[4"7E2<O8)%\M>X7W.D16P(Z>3U]*"*J_<<76#V:$G+;;S)3>+RS:"ZOZ>
M[1OD?K_9N97\4P7DR=\F'_D!IL*"X$/6,8F">F"^>.S< NSJ:\7WFD0%N._@
MO:SR4MPXW>7/P:YO3-@?5B->&/](C9\+M<Y@55O?H&\OJW-J@P/6*]FYU=U9
MF4&AZ84\BZ0!.Q8-4.D(X:((QV,'!V5 D78YQ[!0[XCH1UML8(M<JKQLVKKC
MV$%,J!N]=0'>N:FQKDY2[CW==)F;173&P55X_&N*)=#AQ5]]EY<@TA@+E*]V
M[N7MJDA>?:Q$)E%:K6P=0U[7YJKBL( O7GJO7OS#7H+(FL'7<%!6:@%1_"8I
M"?V140'G/&G@%,40$48,7W C3M27 59:OT#9_ 5V0U8GUR"6"5P 5U59#O=L
MUDUKEI$?0OKE]+D?0X+=8<F+GGSU.#XZ.M)PR"!8/8P7<77KHA>>W3GAV=$M
M<44'^R!Y?-O7[&=\-.&C<'F\>)S3QDK;<?SUDZ_C+Q\>R94#7)>"^\M^SL#>
MXK\?'7Y]M*E?4BO9HIG;QS1^J_('$[_.BV(Z"7P3W(0&BPO&@JPVJE[5^07V
M0O6-W<'=X:S \"8R82@#MGL.SA07^[J*9B<'D5^,V%@TG??H@YV3QEW=8VP]
MCR P_J)M=A(??_TD?OCU(PI6C^KU#=L,$[9'AT='QP[8><->>XH[8M=>X<X*
M)OOK08->AI'9/UVSWVC&@-2!XAIA7N16&%^=>#Q3(3GHGU8)NILR\C>&_.:W
M"?GU/+/;1_V&2.A]S.]^R?VM8GX]YV!WSXA=?<<<R[D]C @1$V,PH$_A#O)1
M0 /\CB5K.K 40]8?#T 7=PSQL56]?8P/XW-<X[]1+J2<!W2=>VI0X!%RHV08
M+<>#]AJ/T#^/3&3'3L^_*[/YT,>(PNM3:-,^P_FYG]&4X<206S6'!R>V"L[?
MAHX?#C9D6I6E1 Q=/%I>/);!]<*-7CFK0_\RX')IVKW-<S^TU4S]I@21?$FZ
MUBK&):CM&C,# MML$/@5Z\N'01GR^E?P-?Q+Q:M6PGMTCE!HT'&W,#B])U8A
MPJ4_Z2-.,VH$/IV<4:>R6,>@CSX8C5>)+/?'0/1[;A"#K!LAK1/"F&I,K6-8
M9,*5DG P,QMBRM6U&GK+M:X92SOQT[4[CWGU6B/WL*6Y^\C6_9B5Y(41T>JT
M9=P#]B;J%= [[CF*M71751Y/4PN]7M)N]3C]].#<F'(ZL3_=8>=BUV8E.6+B
M7E #?(#[M<FWK1!T)",8%+[LK>2_<E9WCJC]:H^H%43M5_],1.U?*IB[ZM#,
MQ:'Q"HE&?!O/TMN[-SNBD'?=O2&Z<([IE=D?=W;4O=_DZ5 K:.:@V7LZ_[@=
M\=&>CB]2=^7FN%_NW KOK-R,>3A!B?"MW)MDQ+W9N=7:51FX8A&HA_NYK 8'
M7L3G'9M;<MCU,N41*(C4"&>A;3BP#WS<FUD1[)*(&'OO<$-!E= %"D8LI-2S
MS=J<5#5=0[QW?@)QF3>-\/Z-0.:)VV^TE0%5/<=X4*'@M3"OK:5?;J2-P_M<
MF%*)0[925M)<II--DX&'%ODR5_+ 95[FRVZI!)1C"V$:I-S+FTMFGO2&='U9
M-51VG8E-Z@\+S3-D(:BOX,[T+()GKP=+4U:*=4FB>5*^)S^G D.OJG,8F1M(
M9M(B00/ Y,1 (.\E[-8#-[-,F_11E'3M9:44@^YAK$OH[D0E0#U(2F=*(^T(
M.?_4@Z!)$VG\!_(%TV[S@M< YT6C*>EK_%W-)(?V _SIDBSSA:S*,KF 06/K
M%#1YP=0QK*ZJDA8J&$8B&DWZ!""M#750L?430N](9C,9^!3Z0_O9EA+9NB$#
MNS.[$$Z%/@P@AEN]ARGE;90O5S4233!,GV8$XY &OCZ.L@=*Z_%6[)K*^3/A
M*7\M-9;/C?7V[,W;L_.S5^].W[U\_>J<*+)^.7W[]O35NY=GY_=MGKL$@G@H
M1%EO1WSO7S;YWDRG=?8!N5)#?A_1!B_R)H4-B@0_VOBI4=S/V'=ZI!#LD/J8
M)L3VHL>M;10E,8EUQ.Z:/V:K)XG[A>(-(0F5Q#UD*ID;AHLD*#M56M5HTE7"
M"&4"0ISQR?61!Q0R05T7QMMNB'$,"JSO/!:W@_;AWPQ#\7NE*3U"=(HQ")4T
MZEO&S?WDC\;[P:![&CH@-[=/ZVU (J'F';BIW5K@SEYC8,12_WA-U9"I,G&C
M3Z4_44-FK+5%,%)"=,O,M6R3QM.)ZQL7+6K!V1&=#@7EX-$_YH:Z1V(HQCU'
MJ=$VLK'U!B(Y:N]IN&Y7(  9<D)YM\//%QV:M4C-C-9@^2!!<B2V-? 2&FB%
M?-Z@?584?">5(XS<-5*7,^L>@RCGC$JL:F>F.*-US]3YUT[KSA.:7^\3FI+0
M_/H?G=#\BR3S\]Y=?RRC"4?1:[^= 6K5_\MI)>;VXY/LG7_\]2@E_+,56S9@
M]1L82W#X4/E"7H*QMD)GGD,/S@24/@HFBZ<3.1? !LR;5GG_M;. /6QF"(3O
M?8:4KGC*TB^)\Y-<VE]!V3=93H;A@5<^5237]D#WKR%G.*<;Z'C59O76)W;9
M6\I%-'EKHE5U+0VX-,Y =!QP@M.'6+&#-U[5U<HP02)#VQNCO90K.#SKFIIB
MYMBA=]Z![RR@0.&K9?+:K$.^Q$-XRQS_\"V&4L(&WHF;TWI<Y55A9Y.91=(5
MK9[ULA)$#=%H(CODRP1KVRNWQ8? 7VG!AWZP6G$T7_/ZJA7BKQW'1> PKK'+
M:Z8=\,!,\H3)%[*^<*'1P#+E$I^X=+PLD5LT%)UF*#W8=81Z*,(VB_HOF8TF
MEEL-H 3RH6E)SD((.ZJ,VC[:OB).1]$+)UN. V)Y*SX'B>AO_CZ+2H-,M<3!
M:]ANY):[Y)XD>8&/X[174[D%H(8\_9G&2LA)&52N,\0D&]+SVL!>5?M<,G-#
MI DT]!:[BS0H)*BL9OD!]>_HQ:)LN(H=,J*T@;6+V<*3)+0I8;E3 V=7(<$O
MB?YIKX9(&R'&$:8&;WR0#(Q$#Q=7$XB\F6*W<V)<?<FMH]0IBB*:N:B9KXP.
M;B. 8*'#VRM9D*XOJX*#FI2<\H:.])YC8^_3J^BR8#"-\Y&4F_<C?YJWH.Y#
M&#3&5T64%KA'??P):[C>\KI&D]%,=CN\3EEK'3FR<SA2BPUIE( KE6FKL;I5
M&]Z A<T!6N3JR-M.^L)(5S_8,\%60O:/]R2G%(>F#CXU*KI66@]BA-:8]])*
MARXW<K%W)>^B,>U+78*\S;6W^._)M&8IVR2G_"KYX'@:G;$>04$>VB.7HNS<
M@6P-CDU',YGEZ!M7]OR%/=0MEX)#81Y9WD,-1IO@^N6J<+5D095FWR#BLV1,
MR_'9Y"P@=_!W[6!'._R8Z"+Y\Y!Q:+=FK?^8X?5RZJH$[>K@U7R.H;G47ZDH
M6"@)LMG!S]=^(@>/<7DGOTNG*4P[Z2$8*<=U:9FEQS1T64TG"] &."/Y1=XX
MF$@X'0ZP/*N2.L-[O:!H"G99'L_E<2 #M#SRM_<P?#@?L@3YI_P'G,5BE%'3
MK%',WUL=VND*;:ZD: ;Q684K8&3(C*&Q0?HWO&!\/$C'R*M%4>/P;DY=U3E\
MNW:*&XF5B1C:2A(55]HW=K"5@)"3FP0DLV7IU&6[3VA (D.-'+S(<<O_EGI.
M%#8^0^AJLB?HLGG.=IS;)'V1L/8&AHTN$CR,6$J]RL_^B'#;T8BLW4463Z,Y
M4IRI)%XYJ$9WES1OH<:\X[G&_&7=K=J4FBDT57&%W>' -($I!IZ$E^"T6L&Z
M)_I$N3'O<SJ)<06,TX<4>:N1[:IR3.,2#[/Y8K6N0)=YLZ)GU09] SYH":K(
M9;W68+,8/3%1<.%P8K]2;[LK5+L%DKF%@4=:B1H3!>KNL)&$"[)(:H( XBFR
M+)T!+.SU;9W/6:]Y3HEP97B#]U8<YK&K!_RN'O,9'_.O*BSJ7<"+;)O-.:N1
M"'OF1<SM01@[W44,\TY@1[%BO@YUG3.WG8[C.C2VX7%Z%,6ED\+ZAGYJ?-MQ
MRG[41QVG6<5M/3%%E0MH Y57*FL:Z1'%$0!#]KC=53WE:8\]Y.(/XPCVJS\U
M$*"^E!O_=((3B,6!TT,AL3$,:LL)OKIK54,3AF4@(@34IJN&7P3B;>"#.8Q&
M^M3,35HMO;M)D"AVOB^_*W"2V97RLB-\4H;Q$XWMX)@XM-,[G ;A&9K8!>I0
MC!;A,C6<-F7MC3^G?B2RI FL4D:^,KR?-#6%<>&+%$6OD"C/3%\[_A<M2UZ0
M>'PYT,)@/(G%W<9RHD2+),W9J\_,O'5ODQD9>>/,#)**PF&($19_LEX<*OBU
MN-MZ+^F/(S$:N\6VKIQOP> TUB IS%G! BYA%WD3-[X(O-V\ZDJ*VO IJXU5
MZ=3J%6<,;;BX)[(<7%$Q2OP(' L1; X0M X#"+6YZ IYQ920B"U QYVSK-Q2
MRH+IPF%:K[;!RX@A]QW:R;"!+RK0@R7>!(T(W_<97][>:NB,9["MBX[>S,)D
M;)&4%&AJ_8P:FQ+<RD1GTR ?)KV<Z"/?S4UOYJD::KI%$Y9J=7*TP37;/-AN
M1>(<W&ZI^;1(&(QK0VQD5XV/SW5:=YY/?++/)TH^\<D^G[C/)WZJ46_8J/^.
M8KAP(9CVC0UZV;-R&,"3-N]^<4\U1\"7G&ETESBZ3ICB.?%C@YR@RZB\/69C
MBEK"B0V([1D1XIR\-P*9U?@R4X:*!<5FIG^"RADKAU[,)UY,'<]<XB#:<,KJ
M]]/)&S@FJHW!H$_U7,RX?Q)'+O[$>1O*'?'KP/B#K.]8<[M'AX^&7I&$#=Q=
M JIXBX17PK$1KLM8DR,NC#%K#HBRFTYKSXL/,>$$WZ%\K>2#P_YO'OI1/Z(?
MR#TXH%2J@4#F+OX$EK3TV#*DF@0;+7*(XBJ8+#SR.TS*O!B=-K=E@#G( E-6
MJ#;]&C7".4H8UTVV;T!-)V1!S8;]B%UF9FAV^DF9O1%R3Z8U6[":?*D!@T&<
MX"EX&$XY.7WI1Q) T/HA=!>"];!UB*BCK3&,?$II<K #QY2*DNSQ\^">BM7@
MQ\0>=D]B\J5#[\5C&$.X'V$,L<:@:G ?AEJ.IQON[W!J6R/+LJ!#FL#M \=#
MXV-''HT-W$],(9:XOC*(8*R6S&_8>VTA;)*"0,OD U7DW,A,;0D=?94^DO[Q
MEV,XQE5M5DDM @/:S&0\#%\*N9!FR>T8R-L%S8AG78B'J<.ZW9"K6 'F<Y,B
M.S<GQXE'H8R^,_.Z0X?OJS@Z.3I^$LU"Y7>F%R./>VN"M@N1<U+#@RAV2MH&
M3[2#M)Y0#1\6F GD,+/+4?F:O-7Z,CDDIY,@'V.B38O5>//<1.*L"740@958
M,_!.,*JER7"NW=(9VCN65$XOB[UA!.'/J^#6^+.N,2-'N$OH\X8;%L#)F%<6
M!- 0PIGC<""/N#^\Q?2  1[5P?NRN@9YNS"].$!,&JZ]Q.";*<>>'X@Q,:2Z
M4UTNKCM-SWA1">]!<J=8*A=0\OO+,';P^WN-^+D?G3R:S0\.H]/661O;-A E
MC##>YF129;"_-6(MI_)EK[>YPX(KKW><__CIY%;/EXTMND#3<1::,DI=(:_R
MYOW/2C;+LV'46BH\:%A=V=:=F$B:X?)P0=CPBBQL!(,@XKO5R'9X2<\.H\LD
M=)Z7%)ERR6:XA%P$'+-];J,7TPCA[<,I@'+^U*K4'MM[;TUIXPW4C'VC*"8#
MTG@)3=J[A#>QK^DZ:?Q#?E0";O\JT37XE'<9W? J/_)-3B?R*GM7N->4EZ(=
MM[\O6_-88"#=UDGD-9@TW$5-X5(V%@KG&&+MT%B/N7#6O>_PP,2E]]Z@WMVY
M#%M4,?AX%[F43Z+:)>_B_,'#\ E+8W@NTXG-.],/.2<;O!OUDD2)ZPVWGS2(
M0M1G^/B-\-9^"HY2^=_+8%ZZCDW1R\-GAU_Z3]Z[(9]CQ.DC8J''1_M@J 1#
MCX_VT="_*AKZ>>^R3W?V+]C9?\Y.G@0MG4N?!I\/$&[V\/6I+?+F1GC$A< C
M^'SSOIU.W-?*N% TE7A0?*#>Z'7B&1)\< ;'!OC6;"TPUAW.BD6.*.M"@FL5
M&NCHL<>4KCU=X(G)= VWF/1A]-J&-F\]>_^NZ,_@L6ZMIK6N/9H=1 !"7##H
MH2^K!LW'E*LNV"%>P0NNLCP5?@OO@#W[(+0,Y.%Z",#0)_?Z-&"J<KDJJK4Q
M6BRY$J2IN^TH&%$NC%9%4C8]W,GF]X7!5GE>,QA5_SEZI2Z+K9^D9W),J7<+
ML/@P'2I.X1>(^_>FNEE2O"K2WDN7?^.+0./T$][$K9%$*BR(9^=@/8J*A6'@
M4!9YS>-8= WF KPB5+HF=I>N"!*3KVP^GR'P?IDJP?WM9<;&J#<"?\2;'87U
M-Q\Y3ZD\ AM;\MJ*7]&WO!F]%+-Y38XY+);W]L"96DD=QK6-N5$KD]'"7/2!
M4E ,4I@!?G5K'0W:ER#%,$\RSY.VJ<P5A>PM3#'F\@ W+GX(N70^?IK%LLVY
MRR@FE:Q@*J6)$8G1-B:*R.$"M+5*A).&L0KC)"6KF?-'&_HO*L1X4",]@@@B
M#"0L *%*[.K$(5"&745<[ MCH=L#: >MR1#K0AFQM2*@&%\!,R/=&"495\K@
M*,?U"3;PW;BIZ]$Y^E7G?/+=!B]G?4IYK>8&&(^=P\:!*T3;@ZY0#8!]U3-/
M@9-O;OE<#SY:I6S:+T'>I_+15#=CQK3!H(_CHX@;=Q!L@I,F]E1S;(5=P$DP
M VT8)"Q ,BPA&] Q*=8M/&G<^O43E/T1T^N^:1W"1[J8YI9WC9/VPT:UR4@K
M<TY85:[#$,<..JECN=U.XTUTTU8;1Y5MV&DX5K-$!E2[Y(/YTBOQEI&K/O2"
MK#*-0S"1YF';; 6G$]A=[,\+D-"V9UJ! ("_P==J4R8^V''X'N]F>'#A)<$5
M,!J/0..6?!"!E3=,8,4?F5C"F2,C39 5LJ$C6/ 5&)@V/42FKLMUW8AFB_61
MKHWHR#1=((Y") .<7]]4:'S9_$C6B@B\4EOK(BE@>BD^'L+"5+WBE6UU+P([
M]8MF-*9T"PW=V]M^P<QTXL0)WFS%1=V!A(DJEM7POMM"V>B@R&':; S7B([2
M=*(HT5OD'.:FO49QPD6%4^/"1_AN*P[:U:#7KCKEET(*=/8\>DM.1/,T^LZ6
M!=MX[0A4"7T#=D.80IM^C,:NI9G" 'L3^U%I5]QCH>X^ H6R$WS/WE&Z-8@[
M=#U=%G0,X'/\D+AOZ^CX\2P[$(3,(M;=#GH#--WL^"!:&SHVP>FR^48_^C#3
MHZFYK B_S_Z85IS[87*_# ]4JJ"N)!&'8Z.,&]U,U3:\&$K\8NSLHB(:2/FF
MZ:=YS8?+?)[[^5O,2-@5#F@GYF@>+. RH7OE+$%;71AZ+S;+YS(QKB!D ZZ)
MR?A]O X_0C).DCF257%Y;$_F@I+J88$WK-9ETK#[FU\1XQJ7PA%-FB*O:/4T
M$2%)"!RY)ZA2@QUYCPZI1\V'55X'QY8T=Y?G'$:GUB++:[\! @J&Q"'\N_/9
M*S"-T9SA1Z &!M(.I@>*.WJQ7D],_[3NC4>@([0<L4<F]Y')1@&$2Y(*41JW
M3C=&0;;QKM-86OS0RV-%V])8% \CSYH,*#'O\3AVM0[<?/K1(T02;M)%?%?+
MJ2 YO%%?1F*,MD7[0&*VM$=@$\Z9;]+CDPG[_*15*=B56^;^>Z:&0X(@!0B3
M-_22?;S'#D$7$/1/#PUOVGXS+476C."50LY:C]HW12<3Q=/-T:LVG3E=\OWI
MZ9N0EV'%VXZ4">)F\Z:E&AW6*!F\-U&>K+1QFE=8H)K9VM?$UEJZ*G4I >5I
M-!OG+68C2)T)E3+?&G/="8;K$M#A.+_1F^##@RPR C.JJN6[^B<*SIZW_2+)
MZX)L[4;P21N "J&DKJHF'XVZ4XJ4XD>4J:*-') <2?^*TMG*I CU4+4::Y2L
MA!%E20.K6%37%C3CWDF+RHJ8FF/=C585:*F+6T6W=F3@EH@;+N#ZI<X_IA/]
M@2$.!"SJXDA!/WJ(_HOL3ZM_P*2_!!$"YT)0S^!TD(&3C+^\$?AK?]./9\;C
MP>DK:S)Z^&XVC*K13]\Z#<#J"H\.6H1 "G,"1[A:9-8CAH.P)'_<B)G@1A\U
MK9R*XSQ:TC=)^AXS=B,VAM>C@FJEB/=IN<*SBVV2;3H%[^5IR8\X7#<O620/
MI;W%6XUA*_YZ@3%X73K!T;N"N]YQ3*9!B()=+IZ#V(&Z:>J I-K>PDDKWT*/
M5+@>%@3]8-".%!NL&/\O>EN,FR"N3ELO.$!]FTWNS-R@CG[6[]FY_76/P7DV
M2S&V[Z[)G!65CKR7J-5\8F]8$!R"QFIFB7!'(=(5'=S,+'(/'T?''LO)UG/O
MP(FR'+TD/^ZU1]_KCWPG@Q;P)<P6/"G\WKO^_,'_&8J8F&HAOZ\3T)#ZZW:J
M86S/>(LJKPV5=(!PJA:+!_.DH*W27!K3!H(1!_&].$@C>"60* ?P7S(3W14'
ML>?B<9X"/KW,5WT+2&I#NS(X68AS+*"17U$HNN$0IX6D>E:I4,+A+Q8=\9!M
M)YIR\F1YL$!6^;62J3-VP2:JK2('I9)14;#&8+!>$G_6$4Y;/X4_JJY.#1=V
M8R]V*ATO6Q(Y,-4UT$MXU(Y7@&[5[#E:/T^LQL?@B([W."+%$1WO<43[JLH_
MTD/0Y^5[SFK[*3B0>MAET=D5'UP_YDS=(^?)"]"L1;7R@IGG8<<C.:#0QFW:
M:*MGIB8OGV)#']YW(;>F1W-)CTJ!(G5@:6P;)ZI-B+4?2\D\'IF;!Y^*%!F[
M3+)("PZXI/\/E?%[U8X#U% YUAVF<(L]G<Q\XR!DNG 9Y=GI ??*@>V\1@M(
M@.-I6F/^2@\_]SQ9Y@KM1 P=87DJ>X ^Y:CX^5+5M4H:3.U2[Q9C@>GJR("\
M-$K)].S G\.@"'>.!OFBX#7,;S(M/%'1^#-%M\FBQ7=HA94,#JZ9I.K(D2(+
MK1L=>QE)@93V[*,O37M945;+14MB5\AI#2_]K>;5LEARL,S4*LTOUWX2RF]Q
M0Y%K3ME:C(<2Y8:)*%K7J]&!>YSW:Z7G'^(0P%"%UU8K]3^G RU:SFXR/\1O
M.9-M6[,!5BP(_DTG8?98:X/XJ.E'R!+INX@*8L'PE 42OK3XTELLT-&XJ><0
MVL#"()DXXB/<0*](5"&W4RE.?ZA<@Y6*X=DX</NVJ!<6%=L-BBQ2XI5&@$+C
M*QA?N]#U]N*M+>?P/FT3QI-XC8+0NF.R-3Z7;>PQ#<4C#+CD$@R->=:1RGO4
MW^1N9XXEH,C)MG7+?<J7H.2)%BAH^9++%J=%IMU&?ZH.)QGD8$<'#E4*R^H&
M Y<4!G699*:(V##C I=UF,&0_K$TFHV#V+L4]V1:LU_9Y/D1!.W" TS?$G[U
M:P"_(G()X0;%>&I.P524_W5LF<(6#KD1>Q6-2+15S_-62<T"N@=W&8.7KD!!
M*BVEJ[:\!>K JW(4SDI'=B3Q^NG$U46&&",!ZHPEYSQ.,M'LS,9D:2XPZL&S
MPW$&D\/;9M@8D ,R&'ZX0!I+"LQ*9*FJUQ[GQ:Q/E4''\=JCS!#F]8,^RP'8
M12ZG<9KJ^[99#4YN4=2+OXV1T.E "<(Q94)KU0BK'-R;XAIDV'X$+?DV:HV1
MR#*""86M#M0JQ=-8XB@#1]5OB^2JJDEO9B;-V:ZY&\8IOP& %8Z1#@"Q_4QC
M1KY98>-(;',X4(!-/[-RIORDY 5EL4Z5%!_S1Y1TAG.\2/)EL)DH=E2[PU@B
M]PJ^PK#0*),8L8#9VZ$CS&%",#RZE!GENM8B"_V#));$_<V;SBJ'UMNN ?*:
M-UNXLX=UT&X) HO3V_I]F]F.*@[>#&^1)>)$O'>D[R:<@+7G=!0C]0U838[C
M('(<Q\.8F>WUY/J& X(<EQ\?1:H,L8]#5#[%@L<S-/N3^7,,J'Q,L.]D'^S3
M8-_)/MBW#_9]JN7[7BS?!'9"]%9S26S^OJJ\T!-= +[2"AEQK8MZ"VL36X?
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MFN_1/LVW+P#[U!.YEHB\SUKY"WK"7L,T5.IG6M#S4=0(M>5)<757]ABK:N^
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MOII.7N@:$JN7-L+ 3IV.JQY_8\\R&52$[S((../ZX$PW-DR0._D+=]!/2FU
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M]0-" V3>NWDJX;[> G$Q5(='P@.-'>;EQKGW=+C-D-C$06AJ,-7_9G2];0M
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M[$UWN!H/H5+0-0N*+C\)#%6\6^/_-JVW2H["+"YS2K:O+=.<.1Z+"Z*E58Y
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MR-)5'-$\*O(1F%]E8*$CD[U#R\(!AYZ_,':#>?PC?A;%QF/\7:0YIOH9OM1
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M^MV1B[M7::G(V7((@@(Y23@"$T,;=?/CNYWP^>%$3):%Q[Z6-;(F O7P#+D
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M/QWWH1=POIT<7UVKC58(+PH3S,9U+N]& !B_7!V9>'R9EB(53NPV?:4(<'4
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M94$[G0(R9UC&LV#4C_L+# YBHF*)*-@H&9&\N7K;VZP'6$"R BC  \MYON2
M&Q_X0O?*.5,- L^J)YPC0(%?K**K?)EA.09>*.[F\PN!//\[K0"->?LXG\3P
MN*OX8KEHL1M<IJ%-Q_C%K=;J^MA[<'V!8^^%J)&4(V40A\6!6A?C(KZ".^L8
M@U:*>[TE*9\W[C%X;(KY.2ZFZXLNT]A@#$N,I/<LV.>:9 41F,R("R#$WBD^
M$.E3*.36CY(L&6G-[Y0"07!4SCVI"I?DU"-A5=!:-,XU))V2_)E4#4L$BO>U
M#9$I _:%*D1ZAF!%58CD: 68 =L-3SR8%6[ME<P(!>7P;64.YR!&ZN'DQ'ZP
M2X-E4R+.Q@":9HH#Z0Z'S*'=R24>7/P9.T8Z;L+DE+/I@XU'2)=.*CAZE*!(
ME)5?H*>:F*+CAJ J-[,:"&JXBE4NW/H4('*( E7]"+X.#0EG R^-+3&"L5L6
M''UM$U3UZ0*/->5I2<9&\43&%Q-Z7#63K;QE*:^I46$XE4]'"5FACR)*R(HR
MJ,LD2(LIFLUO 8? <_VWL&ZX('0\8D2I?9:M_VGYOBIUF!)W1\[#<X.NOT-K
MB,L?"#9+7H#"O3*>T/!$%LF:9>+A]07NB9=R3_BI#>"]@:UL)YO."ZUEL%-?
M(0@ $VF*G.IL(&9YN4!2 CAQ9ES-"X_(5T207:]U8\:J7*3%Q982EM1TYDG(
M1+2=DT$I:S%R13<>E2-<PIDH36H";*-R%$D;X2,]I96#2RU91JY^W#R>'D)2
MC3%XY5?MX\+4741](]*(3A#!)=&,\J13]\Z+%3D,07V@;'T80D[D3!9N!)=B
MDI[Z4W(F2B'7-U"N2<Z,I@7<CF@%8&K.%T40#W/D&?R9/)>@71SAX+R+22:/
M8/G"^B/13+AT4%ZEAYG>?)323>J3,57&-WO$^$6T/CF^G5S+JW6N17,MK]:Y
MEG6NY39W\"NY@Z?)V%^Y88Z>P\.6>]$766$9$2/& ]8+TLF)SM%,<W #0RM)
MA?\:UA4&1;CZ.#I= [U6'2:B(JNP00KYYBC@7%)P1PMFR/#5H\V+L35!^8"M
MGBSP#E$R=X7T8RAJC+(("RZ_2F9E;&[]%=V0 :.4*,\(#$@XT9!HU7AT@6_;
M#J&P""=IK10)*K:D%=5$!G[3$%EXD@F$<VZ,<8$\)+&R8X(KA>!$BA?9\5A?
ME ^N+["]N?KJ*%Z)6;.(!IB$DKQ7G93"[K-I_)$"'G/Y-K'VK1R36Q@AN1US
M!5F%)JS"D;S2$"RCV>[+4!8.BRBBX SRJK='8(USQLB4SJ@+<(3^)=P2@3XY
MPSPFUU4+6;&2UP:8*W'521$OD2!)&D+R-@G%??L4_8YQG/MZT@G'-^)8R_.<
M2)A0_05;483Q PHG3+#/8_PVN>O*2:1*:^S:U@(O$5C6Y2+AMR9<>%O4X/4:
MGIK1J7P[7KFS>/:Q6,X7(SG)&96*PD "2J7?CCC*@4]5YF0RV-F%P@$>L9?#
MX:E%L/S,2411*A=W""%BD7!'NDG33%BV\K4//(Q>"M$$:BZIREQ CECEG(Q;
MLQ%PZOE,G:ZZBWCLN3I)UDZ#)Y6U!HL@GTS<YX4L>KP^)Q]<7^"<Y-K"/7C%
M/*'W@$F]$ D9;XHH^._07-ZX7"B@;2J+*HC&2I6>WW_-AR0=0Y0SS-S%_N\\
M%?'#)LBDV>*&*)>^VARN1*W&4MCN'9Y4L>'&/J 3BC"252K+V[3AAIY> W_-
M7:T^/;+;:?J^ZZ+\GH$75<9@?S,I?U;!9P=R!C; ; VRMVJ'$E&$5AE<I'-B
M0M?8 I^5,E&(@5"F!#<N'RGN/F&[=<7,30I+0&#3<CJ7 T\N8OONPDX5ZJDJ
M^)_K/;BN%&]KIIEHI L,9JRX3;5'J^6,,/-NYP:*]M1O)U9R6FB*5Q'$YJHW
ML=^F6VAAF!**E&E,EPLIM*L6V/)?;L[V4-W0(JP8GR6(H$;C?Q)>GJZO?+O@
M1%-%'"T"I_6 $2M!)-,R]#!D%V07%3[!ZOOG(@LTW2H.Y\;3@(.47Z%:&:&%
M$RGZ$?I;3=X8 6'#5.OJ2%KF<9<RR^BB\"8>3].9Z%A>)@VU^ W,#)6B'6T6
M99)'B)AA (+G4PMYPIB?_X)K54[>';_=I/_ZM)@;#9O$J[B'%.9T'V1>C4IY
M)YW,W8Z^$0>;4E&\5,5[)8?6/#L$\K!>&;ZON=1)#]!@V$) NYSGB,=@JRC%
M?$;()REJR]RP,>S=W)%H5SNO2 #/Q&Q07*Z,00!=# QS_#KNT)6*IUH)1#JS
M>+&F+I/*2 M#>FSO(LPL9JN^N\X:ON0!<6;\166!"K-J7Z:W@,%Y7AV4QV&5
M/#(+BRNS][U0W@['5KS5) NAD<S_=KJ/CKM51 PCIJ5LC /9P K66*D_T P)
MM"O;7Q=.J$ TH0AJ-".7[3K115<U(LT4V V=_?3E6045@2W W(PW#4P:A5P-
M4:>Q7KB1<KW#D+'YB9J05)$B>H7<9:-?2GFMM3/S /L"6XT+K4_0@4%M4_@L
M[ #ZQUO,7]"_DL5H$[>>RJQF<<DVY'R.%BRM$.\2@&EMB.-C5Y/$_OL\]1 !
M7Y2F5QKY$!H*#I#Y&E$-N6<]=$7>HZH@9-ZK$<7O\%!M"NN,E8^5:(")Q8!M
M+WD![/EXS1+U#67T?EAG]#2C]\,ZH[?.Z-U&NX6KI[8-;88WL>K)KL@DW::1
MZ 0NJH0P@5/'GJ9$43&\B?4(<V0^1%7(%8/@+BG*WNIYXG?[#LPBF/,91IBR
MJ%AFB1!B>($2#1:K I&4E\33L_1\*6R 1>("Z+"M*<[+7!/<D'$13Q:^RC>X
M@X0HPF7@[L FHD$>QX#H-"F"3"K[SNSE))3[E)0!8QP)+:="C&)E-H$'4\?6
M7O?&7!#&(@S'N/3HSQ/R+8G)D9L!O[A"/I*288GS+,6@"/\T3@DD-':_, *@
MUH15P&T02/)&LV\X31D%P3TG?[>C;/$5;9S'L1D?V<&"M7-;O\'9\F&P]_OP
M.#K<C?[[_?$?T>GQWF"?SQB,H1]$@X,_HL'VZ=[A 3SO_=YI/SH\CHZ.#[>'
MPYV]@S>1? 2^O'>RLT<?C+:.#]^_>7L:;?U!?SL:')_"O]X,]@Y.3NDWAZ=O
MX9WT^WZW S_0O_>&)]%PL/TV^L?!X0=X]CY^?0?><#H\P.<.]O?_@+X=1OB%
M-\?#P>D0GC?\)_XY.AH>O]L[/1WNT%N/CO;WM@=;^\-H?_ !3.7A\1!_O75R
MN/_^=(B/>7^P?7BPL^>>V^WL'1\/?S_$;_%[A_\\.AZ>G,!/-$8GT>XA? #:
M36.$K\$1(\.;9 H?Q=* 1:$K_;Z[= _:D7N_;9SX(KLC<HIW2=&B]^OW>]]B
M?W0R[KOQZV/T[GW9.^AV/NR='L A$7W (^9PM]]4ML;1<XP0>W([A35KI#-D
MYL0DUC);^>(M3N"$=ER\7%SD!0JNJ,Y,3G)&L;NSZ4*>I$6Y()'B$9>5G>67
M7Q[@<_]KY)2.<]2 /3D:;,/U\%]_>_HW^OEHL+.C/]^Y%U?I>'&!'WWZG?,M
M,5(=STMHD/[K;^0;_7IZ?/<7D!;Y*,YT=8*K]C?UM$YWHNU#[,_!?_WM^9T;
M_X7/_9,WT=;^X?8_3OK<NKV#[<W@%CC=,>W^$]M:61__8;/^TY6_^1K_^Z7W
M .I+,.45]PWM_0.J(?J9#0ZS.:CO#[,;M:U,TP7_.7[L&^K++M*_1K.>_?0J
M>H>9S/,E4F_"A;B0L^C9RT D.=K-\KRPO;C7)?6YE\JK[QH-DR\Y<%NKGZ^=
MS$JT]*P:+>5'WJE7+UY_IQ-F__N?+2;W]!^_>Z#+W<_JTWMHXE:1YQ^SU4S6
M._C(SYX]?_KLX2[Q>U[7%#)_H,?44;S,HC=Q=IG.'F@+O]""O^<Y'CYY%Z?9
MS]S ^3D-Z/\IS\^R?/2QW!SET[_LZC]%V-U#7?[;%VDRB81V"R6,L&6'S./\
M0)O\X)JU&W_Z^2^[NA_HG*R;]9\UZZ_@U7T@FG3BP.:V+7(DQ4^9(D-2D 9U
MSK0?O8=ZE'\#S?*KZGN* /YV7^'B;RW*_>73#?\Z'KX;[!WL#(^[G</=Z&CP
M9A@FWZ+]X>YIM+4_./C'M]:WD[TW!X/3]\?#;H?ZM8M9S/?'VV\')\-C^&E_
M__##R?]\:[UJ7&<WP+!^7,.P%(;UXU\3AO7P3[J'W\(_96<_^%;_RQVIW8X[
M<>DB.4'<ALLP12?#[??'>X3XT*]$@S?'P^$[N&WN^1C^1N_[/SVKS=5(3$U]
M[RGMR&2TJ73[ZZ>T'SU XDO':ZD^T95N_1Q]<YWX1L?^U[W?#.H)YF#@M]&)
M;*-54/R.>*+U_'SUO=$T+S]_<]WY1F>!8NKMT[#>#5^IV4/4@NAV!-T2K;?%
MG]OL716MZ'8.EJBTV3HCZQWRE9KM@%\>](46M+>LOKD>K:,$7V.I[!A]':'A
M+H.%$VVD+'W%,D6E4]7T6IJ]]>):-_NZ9N]\&&SS<CNAHK;U>OE*S3Y9GI6C
M(ITSW\6 &![6=_)7&_WU8K^GFQ=_CS&^@9..N*>Q?OC#>N^KX:A(GNPN69KD
MGD?[&UW9]^_^8GR=/:WUF'^E9O_KG]SP_X&1;].HJO!V!P1J%?VJ/N8N1A?)
MZ"/S.2%Q6OX)C.M>$Y<F"?A@@N*)Y$Z00&^N.1+BH_.Y$R^UU]B*LR32;XZ-
M2*WP60G+HWV9E]*KM\KSYY'D?):)U(]OC?0[?* C)EC.8$"4*I$)W#)D,I3?
MT==5H]=S<Z8E2AD5Q(B\D:8]$2<)/L?, D+_ ^V!1T8;SZD"9#;F"I">Y1F"
M(<,:7V77:N8AH!;"&U,6$'/M-,U$8L,J:V;PB(TSDK-*\\)SZ9L>T;K(B H0
M%P.-6X_)$APGH!-!E=ERLBQ%;:Q%RFKE!67[@29,18V%F)_2C_1OM[Y8)VH#
M?3VG>M5S6#750";B)C\B5KBQ7"3QF"0GXUEERMN9U1HZ4VL#\B'R6 A!U(V=
M)/*I._324:4NG$:N+BI=;SOW07;_%4_<)KS,75M]$[*FVI?;80(?8,,_>Q)>
MO'Y0_;@E*+.=FNMXF25/%%+4!OUJ:4]0,?VWX-MVW Q$C)[6@ _3%8*0)_FO
MA3P%C;RO??F?K.7OMPYW_D XZO=O3]_M__;_ 5!+ P04    "  JA%I32)J&
M4@I1  !ZLP$ &@   &5A,30Y,S4P97@T+3%?<V=B;&]C:W,N:'1M[7U[<]M&
MMN?_K.)WP'HG4^(6)$M^)7Z,:RF)CK57EG0E.I[4K5NW0!*4, 8!#@!*83[]
MGE<_ 5"4+=E*HJD:QR9!=/?ITZ?/\W?>O!]^.'S;[;QY/^COPW\#_-^;X<'P
M</#VS6/^+WS[6+Y^LWN\_VMP-OSU</"/1],\JUX%.]OS*A@FL[@,CN*KX#2?
M15G('X3!65PDTT?P0_CIR4U_]SJ81<5YDKT*\-'MUT$5_U9M1FER#A\5R?E%
M]>CMF]VW@]\NDE%2!<^V=MX\WH59G]S%>/]:E%4R73YZ^_=L5,Y?W_4HL*ZC
MP<'P_> T&+X_. O.!GL?3P^&OP9'Q_C)0'UP,#@+WAV?=CN?WA_LO?>>A;\/
M_CDXW3LXZ^\>#H+W_5\&P>Y@<!2<#GX^.!L.3@?[P2<8Q']A_V@??KCWOG_T
M\R#8._[PX>#L[.#X**@/;7_Y#G[W:[=S-NP/!\$!#G)XT#_:&P0?3^#K_A'.
MY</)$)]]=WK\029QVJ=//A[M#VIO[^\-\;4[+Y\^#8,^_/O# ![;#S;PN;^G
MDW\O\M?NXW\OZ,->V.W (N!'>WO'I_L'1S\?_AH&'_I(OB&0 -[ZCE8/*SH[
M/J35#DZ&P<G'T[./_:-A,#RF"<-3>\,#H)HS5UHA3&6X8M:G^EW=#K^L_TO_
MX)#VP:5#B \#N?H!O/_H#'Z-W^ \SS[N_C\8'R83TAC.)$X'__GQX)2F<89$
M:I@$;B.^F&B .P%<@KO=/SDY/-BCJ?!F6;\[['\ZV_+8"-_CO1[V_".]@/96
MF&S \[!_BB0'<I\<#O9_'M!L]HZ/C@:T1C6;8/?XJ!^\.]@?P..G/\N,/QX1
M%8_I"!P> P'II?"271! 'X'7S72V[O#<C^.LB@LZD.KD?XNQX$Q_ ')^F\'.
M!J?$,W2<B<&/]_X#&1A$ .SJI_XI<.;P&\WEYV#W$(8_"X%;]K[%SGH"?4A\
MO3<X/#P[Z>^!Z/C'H^U'].^3_OZ^^O>-)W*53*H+?'3[A]?!*"\F<;$YSM,T
MFI<QS$7^]HBNX#?#4S7 95Q4R3A*U:2K?/Y(KNDWPWWUE+S\Q1-X-TYILTQ^
MCWE>0-1WQW"6K EO3J-9DBY?77=K?XJ*(LJJX.PB*N(27A?^]/*G\,73[3>/
M\96H'^RWSN7I3S\T7-BW.;UC>&.216EP4):+.-B/*GCG\;C*1W$1//DQ#)YL
M/]FQIPI_G#)]'],FO[T%EJ(_GV[M/$^R1OWD($NJ!.8X^"TNQDG9/LV[5"?D
MPR2;Q/C2[:V72?9M%)GFD>6.<(0.*@Y-4B?8J"YB==F_^:B8\LWCCV_590\G
M&0[)-(&I5A=1%0*/%<%EE )3%/$X3B[C">@#_\7K7?_/_P[@-4E5!E%9PII*
M?R;O\Q0.L3.1I Q@G4F5PHC!8IYG ?X$I,P,WI)-NIUR,?I7/*[@&-,W:3)+
MJJA*<G@[/!PK)H%GZ?MQGDT2_OHB+F+@]BF\+"CC"M=8781!5,'#RZ""?<$W
MP(SY$?SU!%B-?I=/:>[=CIE\(U\Z:\$Y\!OG10)_PI2?O]K>#N9;LZU@ WGB
MU[SX'.PE%0_?PZ<]OGY1&W<(M(!EX)KJ0XX659#E%4Z^B&D=(0X+1"O'13**
M:6-Q7O-%,;Z(8-;3(I\%>&6D^?@S,.9!-MX"H@3[<1I=@=3J=L9Y,<\+'M#;
MP+U\-@?BV5/ 7<,AM:@+2A)^P494!M;F11-D\!EL-A%X ?R-<VWB5&!L>H6S
M4M@1&'T&<SJK8.:@<<%/]:J X.,8G\FSF"?@_R"@$6% X#@EIN'!- V 2O&_
M%["SS&+=CM[A$WPK$*<,)O$TR>))D,#;8$%(FB<;H][67T8*/7N.0\,>J>7O
MX.YL!?#)/M*&SQQ]UNT<9+#=? S5N>43K<@8IV5\A6R !+6WA#EB"G=[?I5D
MY_*SB^@RIB]F<93!QR7\; )W?,4[0B_0\WKU72ASRYO"?]*[;S0+?93ZTVF2
M)JZXZ':0?B6)OY.X*$G8HO2?)"#UJW1)XCO3_ZHNBGQQ?D%G"KZ9Y;1?N"7Q
M)(F*!"</\K8J\K2DGY;JGR#-@]%2/N.#-^:S* ]T.U=)=0%BA^=!9ZQ<C"^4
MY(>1%B7O+DHO^%59%0OX@%]VNDCCX-GV<WVH8]S_10$L!R3NCZO;.YA?NA/W
MC!]V$[A+29Y9#$'GJ0SEDEC2]<<GD.7I)*[H\N'=I).9%&6%HM4]IN,T@NUB
M92*(YO,T0>UW(X+[G1^U)7&WD^"3<0:7>8E'&$:'V=#?8+N#81%-\*4?HN)S
M+!)AE$R,C/=?2/,G(8-W.K#,OQ=QR=>7?)'%>)]4\ K0;NCEN-1>MR/ZACLD
M3N/J(D%N]$=JG3GP;Q'#M5DQK>!VS6=PK9\'AULG</F/HM)?WGZTY,OXY:NG
MV]U.U*HD@ 1]]FK[2;L: 7<PW$5(:B)1J>GA3!W/%,U=SU,6?SS<^\]=7 K^
MY9\P$U&EW,]QZ:AI-._/99XN@/97,>KP2 ZPPJ+S^)H]HQ-/.E?K1G4[M%.D
M*;GS 8H3IXVC40I<NS%N9#8U[>9=(T+)<AI& $)HHG8[-Z/J29)]#H[G\(TP
M%2XQ"DK07].H@$'.X2K[G;4L_.8\SL9+I,@X9@Z%;4=5>KK(QJ+N3F40(@O/
MJL?DG^5 ,R09*#7FJ,Q1\56Z4&WF9:[G'.(,-B8]$K>@$>6H3@9CX-E2+N0H
M*5 @X3K83( W1OQR.$2>ID7ZDBTYH@ROE1B(@>()MZV(0+]"M3R%JX;E_'F>
M3W @N!9$V+"Y4/)8L^A?>8$LGV1\"<5&$(GR 'M$6Y$OJK*"S4,JXAZ"9@QW
M#+ )S 3(.Z^08Y1B(BJMK#..R>P NP(FBQ(-1F!1H'7%>91H<2@_?KAM6#M4
MX_^OS<W@71*GDU?!"3#V:Q@$1'(V1@]&L+FI/"#[![^HB?+PFU4^AT>>S"LU
MH<U17E7Y[%7P C\3)Y#Z;#>-@-MVMI[#;,L\328PA1/WC;0@FSYO'L.H#1,8
M 9-\WAS%<,AAEG.:M3VI%PUSPHG>=$B+-(^1-DR.OSKG6'K*H@2I4<)1AONQ
MIJJ(EK*$\XGGF/YY%E6+ CX+^5^@$:J_XX-\>.$2B.!P _. F9?&Y_#G!3),
MM&3[(0X^@@4#<NBL@MN&E%EY :D(_))1E'U&D9* +II4"Q;*\G/Z'0H+?3VC
MV(T6U04(K=_YSBG@$(!J3<(#;&W\B 7M>0ZW98:F,<PK&BNS:9SF9?P@6CP&
MV8,[IW*<2,JLL03RWXL2ORF#/?9SC65W#C++N4%&1S3#2PENP'(!RD2,FX#_
MPMLE$ET!?E+0+16ROD9:)MX>\-^'[?&W!Q2!I"R!O"T[Y!XTRVK#:W?PV_@B
MRLY94^'7/%"X@<)YUNV0KE67D.P$)6VL)&W,Z'ZLY\PCY>K]V_;6]H[1$D/:
M I1[HO^E44D*4&DV"32O7"E$J+R;KV"/09IJ-R1J2G!J\!7H9^:#1'L[>=C1
M53L:#."6@/V!9\OF^\_:#G=O S%0SA:C,A$/C6S65;Y()\K33@]=D'+-CF-\
M30XW#]U/8 !:'G);L0]A^\?I O7J,$#_#2C:ED->+MUX!#8AV&_3N,#+KN1?
M4G '[(PY/WDE'EA]!R;DX"'W,#D1DM*=QSC/*+"'FCLQ(?Q2G/^DS=,_F<'H
MWZ#'A?KM5^C,E<67+:N7N$?H>IF_.Y/<,U95 KK;Z8^K9N%CB70MSN%AY-6=
MET^?N;>N\C44BU2N@"(^7Z02X)G#=;M(S^DBKG34X&%3O$UA'VJCHY?<N9?)
M!,,;K,H8[0<N@BJ#GUXD<[!^"QB,#K@\PB)[D3F?@#3/QXG\_E\Y',3@$B:U
MP,N#! $\DR;1*$G14A_+E=/M\*-\'ZE/+;67?2.9<H*09VB$\RX3]J;@(>T9
M84%'>4E^ 9 /H)0_W"DUGI#(&!S4\R(FO?;:XZI^$^B?A.2=FY@@Y7,.OL/!
M!1EY[EP^ZBBKF%Q1!A@$CJJ\6/(>5OG#-GG;=&;I3^M(5"-(GSX(TMO?#:4X
M+5NB9J5^P%>]D.+D(@3=A@*;MF\Z2LM<=*>8E20*L=GAMA6O!E5F%D^Z'921
M8W$A-*8L/.RGMY\2J6CS)9&#:'6L!U[0')9ZH'4;K9D^S:9++7#(,8725M_+
MU5MR70Q'G8ENQPH$OJ*/CWX]&P3]&:Q^C-2@CZ)R$OT[V(OF"3K?[)"6?/5S
MFH]6?G-&,0SW >4$E'BGTH-#/\*T(8Y&"ON ;@5W)AIB-J5 C(/R='Z+J29_
M'H;+2C R4<-IU&[43@OOJ.=)5 ]1W34^D</#/=XYN&@+LD'UP_CNF@]%DA=F
M$2BZ&&2:3 KR6<-S+YYL[P0[S]^<?3QY6UV\>8S_#?J@)2]@^W>+//^<+H$R
MFD5V=I[LO&3/"ZPXC><7F&Z1+3!Z'&S\M+W="UX^_7'S^;-G+XV#1O-+\T2[
MG?L5F+IOK//+I_Y)_8;_UGD0]62";N>Z/(@)<-SR[J+M?]*TB)LE!300GY,B
M;B?!(OCR_(INYZZV_ OR*Y2_\K82+&Y(5)U?H32.VTVP"+X@OX+$[NTG6-0R
M6:_)KP!F73/!XN*F"1;!C?(K*!WCSY1@<3_NL772+)Z\AK-!7/T*)R/)L:^#
M7Y"WX.MOE86Q/F7J=49N L9VPW3L1 N+&(H,KX/A<@ZK[1?1*!F_!KU]%C.I
MCG(DP!,G&T/]"K]YR!2Y__J_DDF-<68KR9^J,DC>.D)4EPY<*=F68%&4+WGP
MN7*![Y%\L;J3])X(I^]=$/!$%P2H^@GZX"^<C0]JOT4-L@ZM6JPM4TDDMZQF
M20J6DN8,ES!EI#!76ER-P7:X*V?1),:H#=RA.4=!X>\8V/'JG KZ+[I6V(^H
MW8>-54U6)1/+.;8&O$(DG-,D3A/01)=>-B5K%)-%BIE:\7A!JF T)MT,8[GS
M)4WC9/\=_0.=G[.DDG7&FVA7DSHG?XVJ*AI?X%GK*5H=Y94HOGKFDHJ%[E)8
M0 8#3P(.._AE3/4?VZ5&6]W.)U"2Y'6@+X,55^##&PE8'5?PMB<]VUQAA68C
MP6\OM.D.SSO/8-BK2,I$HB9GJ$!%Q03XK:HX[PAK(1)0T39,O1$YL4S!T:2'
M4^"ZMIY=):/\P#"HJ8B#>>'>E:!.A58^K2A:LG/T170.L@RC X%;^J14\FY'
M:KK*>3SF= ZACK$0FG8$-O,J0>Y13HJ<E-X+H*?.T!I?Q""-)T5TE;'EY28(
M8=)=L,C2N"QY)OA[^I=>Z+S(P919P#C.] S9P'(9Q4 J-%5NMH(M^ P>_+R9
MJ\I9?H;.LEZFUEQ5AE\(%I&B,YZ&63R!O^)DSA<1'M^8#3*^EBI04G!0\QU\
M!2955(CYTE.1SOH$NQUK6)QMA:XI2SM?(B.?"\^H4TI%.%&Q;& +-.6L5^(O
MYA?+$@NJ4SRGZ!ZKU=%YJC[L5P6GUGHW2#4MW29L 3F&A11,@U4+QYWV0@>I
MM+FL'L5WC>+8U'[25DX7&'I)0+RQ-8&V5</R6A?@1US@!: +IAQ (W\?\4N!
M._?4._ZR%CZ!XB-A@DPMGG%E5:D.(-/8MG5 0RU()JL%R@C6?(%6B[3B9%1-
M6+'CR(!%X2TV:96C9]M(I35(SK3257?Q=!ISW!$.$<@HD3BV&=CZ>ID<#M#M
MF!&HK@N#R, J3O6E?1ZO>RER_-#LL&(4M8N\"KA L@K^C^8[&"X@ 2Y(:/(&
M73^$?JT2L.13T33G&;A#*M%*%R$5P$I&;]L9%O9"Q^_&3B]0.=#D"R.GQ#A.
MYI4>/*-7@*JU^]9;/D4BJ?8Z!NX?:7L\4SXBN](2S+8LOTKCR7G,I=81:K0!
MEP3";]FLU\I)D7,^AN%&T#/@)]'\(O3N(JW(-#"D3VBO&)@WQ-:5ZHR*QU,/
M80D*5GC.@?89JSVB),GE$8G 9Z93^;VB-$1C*XIZBP :]T.E_\)9C#P%5M</
M,M=;-W#-';9VZ?7?GFW]M!U>5RGN:W -<]+JV_>FFK=W*[PT3Q\<,HY#YNF#
M0^8/)R/&)"/V1"LWX DL)@ZF*)9?;&.J1=D"M"%!-RZK, GD$<44Q'ZU[!J5
MLLOP 1A\$ 4%Y#XF/25EQ1F.8+6@C"=!PI^3[A*J-&FXT= :J!9<MAZ1-[T2
M35E%8YQ+AQ*LP*!*XY;+S"E<#-E;CF(/+$K+;J=TH)&1GY-V"YYKXI$$HZ6$
MM>E.%4E8,X94!#RQ0W6V!DP&@T)<L?*>X9VMNI"CGV%@)Z%0\TA(AFX S#'%
MV_^_-OJ;N[U@XY^]_\;/-_H]R8>Z/52&VSDM?V#,JIVG/[0LO(84I1:] G7J
MQ[5?]L6P4\ %P3_60<#Z:?ON)^.$-5^Q3P?8&E,"E#)HAZ*3&8%=5#%8OR9F
M:ML#U[M!$M';F^U U/CA6KHPGC+4Y(UU:#N@C4\CZFGQF4DFF]1->%%DLB$*
M\EE]]2CV.S7$$9F"\SBC$.]422;./C7!WXL<!E#2:<-%U"$TCQ?;VQNCWL:+
MG\C;<:J35X.C#V=._JJ!_% %G59!3!I=E13,)H);\PW902>7"I>AJ-U3XCI.
MR!^SL;Q[EL =^9V'V4TFXFUKBN++^$#M;)S,8;%>3L;J!(M(.R?4-6K6JSUP
MS!$6/;Z&FS5[31;D*%B''6J\17D!MH=$^5_$^4J_MG6%#5V8I'Q/SI-&[Z":
MVG79U)]7[_I3@E-)&D3*C81%S=O03.HZS58\_#5G_\O)YY_"UW<-+GCK6K$5
M;O\3J@Q?HR%\C4*P^Y4*P5>,C6SL13GJGK%2G! 20:(KYS6>FF;^O>FNW'@G
M;OT'WWON7\XZ_[R.=6Z?75H-(]*XN+1V%%/^ $EU@K&,G>"NY?E"U_<87='D
ME:5,8KJ@"?BL]K#< /IM5VCUNK8@&H'F ;!]*:B$[D[^SC$0M[X)O.M+Q'=%
MM\OU]MGFDY^VGCYWW2[?TTX\\'>YVXF*6"6')'*G-5!6$H8Q=H/>:M>Y'AC?
M>A,#J%OW*=RZ&R]UD-LM_ HY9.'Q(#M2J^ASK'2-,7P1C='9 >L<EYZK H-G
M>!M;S@<5X<!T0$I]Y#ATBXLCIN")T$,\[!4L5YSI>>NK#%N[01,BC221YKP2
M2KS)2T:05-%*?K<%]8B1W?OF[?U.L_ "OYBO?$WD5QDV7E)'V.*FCQ85S+V2
M.+ )O5XF#4=!:Y08?7S8LY993,AS^B'&VB XITY.P>VF3MTC,NV L+_9+!(!
MF>5$HZ;(X$>\;UV_<STH.\;*C":!9B*])MI4D7^6TE9,7I+X >RB(W6LQ,,*
M#XW!H$HJY1! .;\P]4.>X2U@V9.8 [;Z\U&4TM6@?DU7!*YH/R:AB 753@$3
M7@P,U8KODZ?P]9C'A*DUB"L%3\-/\DD"BD&Y!-UV%FR8@-K^I_Z>"\SM%J&J
M"H^(;SCT1; NPS P]#ZNDE!>E'[/^.AAR&8??6!<]'.41)4F'6E3V;C-T\X(
M((W.> 4?[7KCR3;?[35FG< D@;W.$^7GE]>ZOU> )U)\@X"XF&56;.;337K<
MAB9W!"#YMW:>/4._5[F84:%0361ZMW1H\E:O))5*Y>&8I#M6_RR(JPVE+Y9F
M9=;W$^SRHD(A)@7*!\WB(*YZ3CV51;X'R6?@4 =)VC7FW$Z/D==8&/".+\+5
M?%5^"-?:68E<[C;);)NST;1G16/,F!0_KG9HS_$SL:OVG,>6D2EW8D+1)1AV
M'BUG5E&A3K[S@<>#C=RH\K(LA,E1IZ+AXB4\?87@[V<RCY:F'DC<H2KCQ'$D
MX4*['9O)5N8(>E207,A;2H8$D?(5=-^PUNOF#SAL&:C+I8ZOKW8.&67%UODT
MN<.=V^IVZ+[S]Z>^_(;TMQ%2$>C+A5ET+2IP%SQY<&_P&:74KU$,V^2 17$N
M$E@N\+=&8X1N*OC+7%(Y5 S2TBCKZ7MAD!3R&[P><M<!ZJ_3'3%$(-QU#M<:
M.S36&4O7[,Y54W9PM_.-TH--JE4S"SAZ)$7@;5::1DE:ZD)72?&"G=+IP(Y"
MTV1O6HDZ*Z2L>Q>[)RQT9L2<.8^6[M@4$\>-('=<FOQ[D3 6S22:1>=214:A
M+O2$S^,L2JLEWT!Q!$SWMYUP>WO;NH*T6F"MP+UA3#FJ<=^WAV36=NGW0IC,
M-J5'V8 4%+3 #9!:Q+\]<9[AP)UDIR73ZJ(NI'GZ#:09P=7-"8?C<;&(>X8J
M#8*>7K)"'DI$I?X8JQ<FC !C"-O =V-0XTN7OHU6/TQ296B"K/?+V55(LZ9U
M(E7>]<^&**#/BVB&Q98I(A)%7O5/$>/KRUK-HH4=MQ7T2^XVP+9R:'=?:3^(
MS5@]I7J^-,^S$R3$FD=47:2M08LDT):YIY41XO<L(M7?B0#Z,K?&KQ&AU*HD
MWFRE=&U(@?_>]M_]L$+72>=[]I#.YZ3S/?L+I_-]*9_?#VY/&IPN.*#V(3>X
M7 Z\T(551% OU^ $MYH:$*H$#:P_$8LLLA+<NQV*K9@J#C]>8AF[H9]!>(TF
MV:("@9PV"P]B5#6SL:X?D$H]URS&FAF5GHX?+S+C8_)N4'2GBC;N5?B%HCS;
MHS-)'0P!$?PEY?7AW,A%J\)*ELO]>[/4?6%LYNQ3U% (7[K;.:4]M)C8UY81
MBUU[#S6,D'$ BIOP>MVY.=&"JOI@_Y;UGS3HS9GKD[+K=(@9.:>3]"]/_?K>
MM+\G''!)#( ['&>E) KC^=M=+#</J ;Q'>PZEA,")7'\=*FV80W'L]?ZS*!I
MBZ0P"<6^M3-U:^ANF?5:HLYN58_P9+>C2DVC47X9.VP;V9%MOT)XE15A&]P"
M875!BR1*BYX/^@V2>[)@^!"R$\8*P27)Y.]UOZRM_SI,WPL5R(QE,8D'T/8_
MVKT9T*4Y*O+/KB1'^YZ*UC#744&U$/W-#+6[MJ=RS#V//[\6E8UI4LPL]ZZN
M)PN5Z]:OH3$V.A4%(^>64S4T8<747=;-KO-:8GB4L6F%)B0[.2B1;JX2N(R!
M' 5VIPX\+TXK2.F_4[?N,1@PYV8;E*U09U>NR@IIIQ L9J1:=VS\UFNB)%<U
M>OT?31H@B%--ZK'N)5"J]_>TI[J%VF5NQ86PV4@,UJQ*#)4*,CL!?H;EF/-T
MB81#AZKQ]#0%K(C=;2I=1:53<MNLBB04"\_DXM!GV%1\5YRF(+7^Z(?B,TY>
M(4Q5T3M?QJA!H)V!]7(XZT)\[$YY(ZP19*K4P$8FNY-/%893UDFH1:.:XCSX
M)=BQS?6 9)5K[/OV$ +NG-6!P&3&1)Q#<)%G.9)Q0]= D&//?=C40H@_5*[,
M>$)'M]T;9J;5=DY-3I#1?25;XB)R*U0KNEVPX^H,H>+8LTCRQ^EK:Q17O1M6
MW>16\([0,R-X1QRJN)U,V=0&.Y.$F9$CQ#M&TE4,U_2W'?:?X0644S&KNB!]
M>8ORO*KBV;R*)TXXJX5 C)V86:Y9DEP\,C-CMW,M-](4MW&*H6HP2=A[)&J$
MLYH3M0E0 R_!NICR"]^CI1.G8I>B4W,LSDMV0;M'NL# <2;%NJIAJ0X,DPC!
M$MIE71D(J%J9":RJN(7XP [2)MFRD*QA0V6A&-?D3$6@V5N8ER7A!-C)(;P*
MBE]J<TM+6JU5DAH0\ZVLC \D<.QI-8G3X1=.@S0[0B<4$)<0QE:WD0".'V.Z
M%$Z:PWQC=*(AL@<'QK/)XYSNP7\1>!L%E>$ 3=N<84YX<VK4.SZ ^KBW<&Q#
M/I\EMDH,J0K3^&!!TK[V+M"9_ZCZ]SJ.M.</CC3'D?;\P9'VA^-S-C-A_]X5
MK*5'J8Y @3 \&Q?)G$U&>&:JG]$R"*01/F) H%!>UY_3%Y>H&"2K'*VPEGO9
M+RDKA8S,PK$@R&RKF0>LS%BI*&X!J;Z=ZP9#FX>/-)R4]5@P&D1-1 -!LIDM
M" #W+F2KD5!5]-R;L43X2?6,Z.=6NHA? P#720%OF$@[>]+U8%^E+)=(<WL2
M_-XP*7O#L*?>.073A]%OL6K%Q@"=XM:PLK$:$Y %BTS?YV-ZI:?7J+ S6RDV
M>G45_6;W@AJ3)Q-/C."$UE4B)T&L(3@9*I@AX6>],(T\N@IP-#3U5+7PL7?B
M5J='R8G@;POZ;XD1.4F<YN8/?A+3:]P4E=> &Q#B!Q?Y57S)G0]#SD<)U>#Q
MI8Z6-H1H.9O13#>2Z1B'3/,"O%S@*[3MM>N=O=:X03X*%OJ9D(C68>L3)@V=
MYW<$ST: ;@:?S46*<YT8/JP/4DX4+J[40:.8/6ZDK>,+52Z^S@4!X;:8P?^G
MH$HFXCP#U7<V H4M1HU5L:;#D881 WEQ4V8IR:TT]=QSW0YAW6K5D."8@<2;
M$RJ>S1&_74IFFV&!N&P WCN5.#DNJ2T#5#H)2'ND$A%XDQ()/$[CJ""3RNK]
MI)1I,H<$+UG#(/=:YDP"N\@ST,571U(>%%V1K2)<P>2B#0!B[>;YY[*>H4QN
M?/1=<'TE7H_4*TO2KD;X*TYW90BKA%VHG'\J @ZT!!0"I0YY66GZM0HW,/0?
M+)7;L%1>/%@JCJ7RXL%2N<^8)%]71=Q:1/S%U95Q;YTJX)<__J G=2<HPH1C
M[+F]]#5\:-+ZM>3FR;AJ ,IO2;+"#UMEK_1ZJ:%NUL.XEA-XZ:+H.:(<I](8
M679"4J&2]+!\K2QR4$PB #)Y93MI_9H?LG%ERY@4INI"I9.9_$>>SC7)R!M5
M?AZ3JJ*#&![U^Z"HI>BZ+?VNQ-SLLJ2X(.?[1<$Y6&YHM7DOY;D89=Q*%F\=
M3G+&9930BG?UJZI(1@R4<<)5GG;P"X&.I!(XBU'+I$*Y_(KL4XP@(3@6SD=F
ML*L?"XZOI VGQ6L.1@JAU_;8T:_3M'.O0Y1V;-M BNU^>)Z,/]E&[1OU$8M"
M^%$#,71V"K>Y6RM8HDJF>3*KZZ:;<\LYH"O=,)ARB2IQ97!LF*5,#79AC:GQ
M7"16835/KE5X8X#<]PISNBEYMK,\,RE/+:?W6OH+RVC>];8"OFC:"9UP;J97
M2 ?ETHJ\+:P)$N1P)EV6W0GKL\>3:6\_O;%&>^@&)'ZKX77/32\W/PZX#E@O
M0.9B2<@HS<_SA3:4K)\:<#<)=US+]#>D]Q9/9O ;8JVZ\C%1\#U^]"E4**;6
M87;*9#%UP4R4ILDR0MO9<&V/$21)C'J=W<&S<>K*=YYB\QG9+J<K\Y?T#0W1
M8.8C9I6Y^T3$"X:G8O.(X%,Y7DT_RJIP[]0"Y5!3^!L#I?6Z^>O79Q\GDVB"
MX@36J0O_Z#9'QP11PXX%CC!E(_5)S43!J8!:4+]>6QDQ4;" )&JL/5=-PZ3;
MER/7R)<5B]/&QH@H[6QVBGL7L9 -RR3I%_:I;>!X=7=:O(.TN%[J][A.4;G9
MVN2<-T?C0^/S@=L13))R7,0.=K6YOPU* ?4**)4<:ZQ!\8N=I)RW?N]_"8%Y
M5E]%Y=LC,$^F>:+D':2J#TF T))U#?TCK/G=K'S>++=#\?#"2]2TE_JR D:G
M_"92#<= DFB\U&Y:A^9.PAQ'?NT=B70_3%;Q,(MD0?Y3/$LQ" -N2TYI:M:N
MJ^98<M[; 3=N5S V:6A&J/-D6+(GF9ZE2@DP&HE=J]*L.(7&@&!W:*IKA=9[
MC:WD4.[1U/0)D\KM6MS<;H+&)2W)F*_*#&,N#$,G4E+K]7LZ^2KDVARILV/_
M=X@Y1#R7"-Y/5<?\_@7PUQA?G2]@T\B-ZQ5%8CWW7L_[G9=U4?])5<^CQ$H=
M"J[AC6UNK&N55XN^6YP*BC]3,T#;JR"RU#+9F^K?+ AXJQJ(9Z..$[XO%72\
MC 9JNCW7RE%RN[CQ*82YF*X)C6PD"F!+RES]^+79E\0%MC;GY@VU*9BA21RI
M"[^PKL.MIRR7B4H&HKS0R&Y)1Z&;&Q^H*PN4D1V]5M;D:K%K%Y5I@C[;>OGR
M!T6+ILU5!\VU[>SIVJE0*S;%B:FM-ME66VMVDE1H67=R+MW,G)"D@51#QIQ_
M)W]?QU)NZ$S@JM%.A; YX->]-\D(6YI":RH%].5-MV+U+O!DOG0K5MO+%W':
M%DIKIYBYHQ1L2HXZ.N5CDVZZW KZF;59HL!=1TL=X1C%%A*(Z1/S8H<:)I<5
M-TQFQ^A$"4 K=UNETZWJGS)L7J)N5V&94/!]52P$$3/!#,H9]]NB,*D$6+0/
M3?$.UXS#+Q/8+Y3.&$NKEFU@;HZ"3PF514$[[<Y*-0-7*AX'8WHBBU3 .!;B
M:64K0:N]1*@.Y20A]D$S$WG^NIT1F]C8)HSJ.T,8+MV0'8D_%^*  1>C-PM+
M4>FHEDEA]&),""ER4 ]2[L3A>Q6-.<3[9(.FU.RCVI81![)OP+3 -N $#05/
M=^HT_B.-P"&*EOC$(PG/W!$F8*O3W<%LG&!TDUCA%3G/3'SDX^WU8_G2J3B3
M6!$0_/$A(.@$!'_\:P8$;Y'C_\"PPT]_>/1VVEL;IE5/ZB5"#L_1+9"=Z_W]
M"?=\C3X ]K?!@-P?%D(6M]83AQ$F5F N(]QDIK"WL5C'@@!U@._+Y+=-,$ S
M<N=DJ(_PO<B*H&JN>4#Y;MQ9T^K*>27%4M?T,0D:VY@T G(8OQJBR9 BPZZF
M((W!UA7\TA$JI!6[OSF$I!!EI'?F)&A2*?@5I?5N]&D:VI*>H$F:D ,UC92-
M*@ZR1DWVU36@M'=X(+_XO==(S.]^8:V4)+;D\"7+U]&C3@TO 6&U+&E9+4Z^
MAFG..3K(,;7OMK>>U%(QTGA:U7_0.-SP_2 X>]\_'9P%@U\.]@='>X/]8/?7
M8/C^X SH=3H\>'>PUQ\.@O?]7P;!T?$PV!T,CH+3P<\'9\/!*3S\\6A_<!K0
M>P9['T\/A@?PKO[>,#A^%^R\?/I4;.);^U\?WOYA (/N!QLXJG(X[+Z%0;&A
MG:[1#(YK\SKL?SK#B?6/?@6RX+KZ1_MA,/CGWN!DB*\^&PR#=\>GP_?!P1'\
MN#\D(O3A'Y_ZIZ=]$,##XUM>T,G'T[WW_3.8Y_!X[S^"@[.SCVH/!OPO6,9Q
MT#_] "0_V .V[I\<#/N'P8<^;D'P#G8@.!SN;P7[L*#]X'AO>+P+GS_Y,0R>
M;#_9">'!7V7K8.WO<-> HX\/X<^3P\'^SX/]6UX1T/T8)G_ZZ0!6-02JG<&@
MS"N'@[,SI#G\=7AP6.>CL_[!/G$//L.[=1KR7L#D3PZ.#HZ/< ,/!S\#!?:.
M/QZ=#0[Q>]BT#_BC6U[*V<==X!,X%3"SX<'9.YC:\>FON!]F=X"8'_?>,VGA
M[_W#@2*LIH2F OP$N&WP ;CMW>GQ!_XE4^$4!C@^VA(=@NZ&;W(OW"?31+=8
M?ZI;K.^!Z,2FIGU=*%$^=%L/"*\+/6/[":ESDY(A:<_F:=*,\!%Z"AFV)_=C
M?Y8'C_M%S0G4CU-TN?49JE9VLA6Y3_"9"6IQXG&FEN?V!R6U2-$:$;JK7==A
M8:5,2.EDKO]FU4I;'G-54)ID;5[##?(GA0QZ$5WFR42Y&2?Y8E2%5DJ:RN61
M,$6;.[@.6+G2,]D3\%%01)EX"'U];<@+/5J4$X)U)47-]QH*Z.@XGXVP>:[=
M$@BQ!%0G7=308]FZ$MFBYP8X5@]>SA"OIVETZOQSV6-ZE-P^=YQB+UY2CB5D
MN\)/[- 8VYS/$ZP[X)GZ<1 *X#C1W:I>TF0*<YSBI\BI^C+57K"F&&1<;F&%
M4@S^)G$PQ\,MP"!<$49>=">2S0D.64[!7F_4&H$I>WY]O[HUJ EDUQ:R9L,.
M4R=4Y.*;I:% MJ@F,=RF4:5\M(*.-K^9<\:"1<;NU@E[V*T2."JL<A/V+:\R
M]HP@OJ5)$F2KL2/KE.$L-0)QI7B7 L*HI4)8%0AE8\=(CN9;XL\5=E1 =9-9
MF>]I8C545I$7'$OF<QXIY)4BWG1/VY\2//]+.S@?8#" ZT:1;7/&M+]'/0;N
M![&XE>W98E22F[)2T&#!,7 F^ES*5HPG<UJ;4;[PD'*:"B%T2',\T]W5ARUU
MU0X7&>I< .+EJD'1&:=I2?-H2ZRD,\*+L4MV2TXFN=*@\W;L795C<CRGHJJU
M;@>NB(A6S=65ECA1LD)21ND\KK@VO([>)VI.!H[-V*Q5 ^Y9K9-M-):B0%T#
MS6$X"YQ71:&\P4)/;'M?UTNBQP;?14:==#LN\@IBO5 (=JV,#'Z+N8PHT1$D
M<ONMM*$R;''.Q40QHA5/@X-NW6H<3;13*)I2=->(Y9:]IEM>YT_D"G4G$K[
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M+T7"3).K>#(I,-A ]6@F#PV4<0/XH>[/4\')K>TAC(55%%7P;(P.T0G\F%*
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M4UW!OJ*:'QA<EPRD-,&*)HBA.'M^,V=^+K9783*%@S&V<*?4*U44;3!NW)/
M1A<#F'#UMS4^QY#T#$+"I0"JSC+I>:NK]U< %225ZFWK]XZT9M/0WE:%DLI*
MPG1T"D#3E<I8+^2)'TFLR*ULM@A4(PY%+H2HZ"9V0RTP'VSKPR&V5O]KG>)(
MQ.0S]KFC4%DV$0<HI_5)MQ@S4Z)+FL2+M:9\3P[S_3C2TAHRJA8%YNF&F#^0
MT=_P"DCX;W$U=GI,4T9S3M9@CIA0$\(S4EZ,2H>%24/41X]OM7E2:.[2EXX1
MS'G!50,8U)*@I&/I1@XXB\KAYJ(@'DG"!IR_FTM:(X_BQ\U4GEL&E FD"AZG
M;@]Q3[CE>\^"'2)]E9\_$>3D6U8\[Q6)7MYL$HW7&^,!A@W9EO9%4FN55K'L
M1,NM4,!Y%&C3]!>?C$207*P3.YU#5QOH<E@,V'.ZK#ZQ;INNFJJG$SYL]8@4
M5N6;$,VQ#H#@WOK31<$^2>_Z3R06UM0J3%5AZ#Q>BIXK2E1R0982)2T0UCVG
M\"7,K#A7P5<*ZB\X$1E'DLU )1#Q%["H9)U%.R'U-1=-.UE1<[LT5:G=&D=(
M(Z242CJ9&0GLDL(G;[+>58Q42II+DPDMPE.[V6Q[WK/<P5#G)@CG4D@>4BQ7
M"6C;MY:[T'0?HN)S+.I;2\,#F6&*MOYDI1(8F="H+*_;<2/!O,JU=T:[=%0X
MP0'F0#BF!O"?E:\1_Y(7:%5@9;I'FN_@:4GCP+@N)FZ94QURQCQF>TG8'9E]
MR="A[/;)L(BK+-D%2^Y^=#XR+ LQVF\HUD 9RMB1Q<>@#,8$;U>+JSB VEH8
MQ-H59!>S<1J8^PN*M1LO]5C7/H+HC6>8[*]2W^D<<M(4CG#[O;%N**_OQ:6Q
M5LSXR4/,V(T9/_E+QXS_B'P^$.>4SA;6?1;ASKJ*"&.>JW-$7F,\V';E-^6'
MDDFPM*P,"^&Z)4L8Y#1=7*@Q[!F3D/2C@\SK;5%=%/GB7)7^NBUJG+I;*JMM
M+7)SJE7KG;;M^!E*=*F,L:I?-4#<99Y,V&D0?R;M@#Y PN0CU!15;RQ0,2DX
M9J&#B7#GQO&U4"-"PG&8@JYAD.C$$2#JSW/05:<111K*$BYQXX(H"DHN0QI+
M\3''R[@WO<FIM>Q!]8SJ--2D];!=J;I+4,! 8-LXUJZ=E*K*UG.,NM?S.19[
M(90;7*$%1<_JOD]\[7F<Q4646K5J*";.<V*ERB[])SJA*U(\+:C,L5]X'A4N
M7*V/>C'*I3.-X->KC&JZ;%%[6*?3#(=0./E8!N<D=AY;M6)S%$X%R7HMN:D_
M5#$1"/%:T%1I)["[W4X:GW-B.K'T*D5E3=W:4ZNX\1H67U-E6C'F/'A+>8ZG
MN.LE4821F:TEBU(529DK!YAT,)D%3:GP[)8JK"Q*,'K>1OEDJ;)C_P5GM)QP
M-%KI1J&A9V@(2I.),[6OFGS(QGPLV5RQ8.0:+(@'W>C1VUWI3LSB@Q1-X6.V
M"OS>NIB1;0!J5,9/6S;C>CU\3,6KBXH3ZF)UZSY:S8(FRDG_TDQD<Z,D5(:-
M)[6=5<$L05[%_(M\@C?)"J[]<[+6ER4/_ SRN,BHZ.(PNF(7)R;H@CY9\BYA
MFQ5^1&5)6;Y\5=T,P@63400AFV\^N 7!:JR:(PTZ,_><)B#(O"A390#Q[\AK
MF]**)1>8NBBDDFTC@?I*/.A(P%_SXK-1A0R(;65JF=)8-5^8 E=57+R%+@'%
M,,$@HCH=:OZ(22B6O4YW -[/XCJM4<RE1%DG%9:89\;X=KN4BA691DTFO&FE
M26J:N>P%*$451[&3*RF4V8H!1]T=KU2M$JF]B7(BA0[Z#!QV?&%&7\QB%"BX
M$)A7OHPEA0(SX,N>V5DIIH9I$R1.R>T>5?>12L&@3V,$L4?WU@(NLJ!,&!-+
M-7(1=43MY%:W8^V%@+(D11%?YF..'"U&V.;=Q)!E:%<2J%2U+YQ%&.SF1''2
MFC]$V066HQFL#!3"$PLA1W(6YXO*QBEFR6IEQ"F_B.IC9++C1.H[S""+YWR7
M\:(L3<" @UL-U"$[0^)UPLB"OH&J2E&9-NX)9F_IP(5A[U"A'R4S.S$(WS*G
MIHH,N5.:V@<DB$]\C=9+] XM[U[[R#@,*+%4(L1P2GC?P0%&^)V,7+WPWT5L
MG%#FM]>R#1-&+P%[XEY*R0F]I117DKZF<OTY8RV3FWIBZ+=R*>1$0^0;+CL:
MYW,#(W&91%YBD 3NX@G]A- S2&CC@=<H% 33;<+$\"+U54\#H(@ D^H:QMRA
MM A!Y47"<4YL*4'7!CQ?BW6L71-RU3S59#PQGK-VR#?3EI S*!U7"=VCG"OS
M!+#">'1-38@&SB1+1E'_2JHW=?=+CB&HP>0IMC&E/9WN%DQ; [*?(GV25,IT
M4VMCJ4:ZEMR"N-$>KY(&3&+>!31LL#SY(HHOA1UXL"23JID58UB@7<ELM"C*
MV.N>RJ^:6M+?.-VE2JD4L#$0@%(;Q3_%CA2R+0@;DY5D"U,"ZL2^?2]133@7
M<Q]6 4-&NB<$S!5M>R>2WG0<[DGT['[H96OY0Y\^^$-=?^C3O[0_]'Y$B[\,
MU+E65\#-8)1K:_PYRZ_2>'*N[IN&Z*QD%K?&Q6QIFTQ)5S$WK('-4@7.DO#8
M[7#+*L[-<Y+[)*.9&B4[2?J2Q46>3=!5<A')=3W3 YZX)Q+P>\]"02]GI(X5
M'-T;R/W#QNE13CIC*2I.E JX)F-UI1$IQ!:TE^8$HQ!8&GBFO):5Y4X55\8\
M+A0&7<3Z8:%O,7Z1PC&[XL8;,2G]=H*L1O)4J;'4;*'D4#,Z->.R)1%5XZ.Y
M.,BZ^(48V<\T8P<DT@P/#;P*X;: %*4N05X:NZ*.L:Q?S4XA=BMI=4F!A063
M: 8BK-00Q^W1"431</$@604@UR^YOK4*X\)O8%A<(7**'A+8:H@*<(P6%0.N
M$>VD?\=U6H[=!!0H+[D<\SFETL6V)1\:E<<M^B:S+54] BGZPFOJ=B8+JSK8
MF-_H5-:LPIJAWNHIN4/;6<0P[(.8H%E<6 CMNA& ="V1J!C9,!IG$)7V128&
M><D9J60<);&JN]19(\Y.V_@[:\#O**QFV-*!OBI,$;K5.<PD@V*5FC:<PSJJ
MZB8:?2''O#*.]@5<[B^Q@'%^GE$^E+$*44(FU*263:U067NQ=GW9L*EG/V//
MQO%GV*6#;+P5!CLOGP<?T.HZ7Z W#8P]D H[S]Z<?3QY6UV\>8S_#=ZE.39)
MWBWR_'.Z! H<_1KL[#S9W@F#/J(PX!111UNDW<[/47J);@D'[A4TKG/Z_/^6
MYR,:?PLV*M09B[QW+D(L2GH#%NL'9P3PP?( J*[O(P64Z(DMD+^WS3EVHQKF
MG 8.</*![Y %M+'M, "A_:HZ70V'Z<+SAC)N$^G5-:B4-(+JM5 31\ 2/L@R
M$]J :S;0EW*N+/HV4% L?M73?6+CH(KJ%Q78(HPN=-6$4Y>GHB]-,"9#W8'(
MS,F;35):.X1^&4.C%J+A2_!!13I^RB-D/5:KRCET^<OS5T^W@_G6;"O8 $G:
M[:#3D;V0N)1>()5V$^[FJEHO4A*O!>;3T*'J1A0(? )T.W=- :JIP51JU42:
MX%2=16'\EQM64DJ62ZJ@A5+6"T()JY(#&/N?39S7NZUE%=W$6<<DDT.(C7Y!
M_;C9063H;RS9X7I)KD3W"C_8<4,HZ/G,V:*D##S 6#H*:#2M!P]KSM0=X<(2
M_-XJ1-C@3@%AO[=N<C\TI(3+E+1Z0BK)86+#)*(E96P %8J5@ ?A))C4&8P5
MT=Y?:MAB5R&V#2T?>DPGDVJ "KMJ"*O50'*HEN<*9GGJ9+I0H^Y+X)-S S.M
MS [FJ7,JZD\8II[[4\IBW>=KL& (RI^8E;HPV,5U!8NFWSPQL!DT*26B4M<+
M<FI(,X83G&#(S0?E?^!@FL6_Q#G$)E#-,42<"M=)HB! . K3A/ILHVE*84W
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M8GQ./1\.1$"P]5[QLQ;1[T6);)KFK#02(SQ$T\MY*IJZJF'OD$RXA6#"@DH
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M+<S@3"Y"U[8*UFM'V)7]W?X4>R%C95>)#9\IS4QU9-C!(K9D]*\'YP?P(+"
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M(*VI<S;2<:\J.-W"WB!RJ@&.*O6Y>0$=,MY,S 8#H+1\$E%@5GQ#-\/ABTF
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MB8Q$\)5RYZT$0O[98:2SP,BWD*EPO2'^@"C6,"T&UF"*+[0#@V:*3GXJ(;<
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M%@^Z<*DQDM8 RFV3[A#Y[^(=8LG [7AVEU[:LV_QT<M^?P!02P,$%     @
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MANT2E4]-IDBCS=$0-[HS>M(;#78&]1:50ARN+ LE?I&5+),^ZD-?'"G$E*I
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M7,';YLC4/30%ESR@:FC4XU7*>]6 ,%4RHTU5 Q,KQ (RW@I"Z8O/B!+G$0K
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MA-1[AO=E25@$U^W,^0R**Z$?,R@NH#Y:P@GD62%[LI5#X6MN 8R%&4(8E>
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MI-+Y <2P:<>C% 4(1]-9'QI2[1.,JR2-,"V\7,EM:4?S+%K7@(!V34A:PJ!
M@=R!L!0!FID\Q"LP_R)8#,.EIO0#2\NJ'95*%B HIK<^3)3>"R2SK1 -U_",
M TN=W93M,5O=GP5T08#28ZYUU[:0-T#Q- -=LBS)]NIYNIOM9D6$I7%MB2LV
M('.:";,\"!8 4R8#A0PI'2J$7GI>WR5@F7J($6R.*7-+@-UDDX*F)B 2K,8
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M(DP7W2-?MW:#>S]M\8W[Y=[!:K?\#U!+ 0(4 Q0    ( "J$6E-F<DDI$!X
M !6G   8              "  0    !E83$T.3,U,"TX:U]S9V)L;V-K<RYH
M=&U02P$"% ,4    "  JA%I3I'J'=$LQ  #N[   &P              @ %&
M'@  96$Q-#DS-3!E>#$P+3%?<V=B;&]C:W,N:'1M4$L! A0#%     @ *H1:
M4R>H66_LO0  *88$ !L              ( !RD\  &5A,30Y,S4P97@Q,"TR
M7W-G8FQO8VMS+FAT;5!+ 0(4 Q0    ( "J$6E-(FH92"E$  'JS 0 :
M          "  >\- 0!E83$T.3,U,&5X-"TQ7W-G8FQO8VMS+FAT;5!+ 0(4
M Q0    ( "N$6E/N@]_3%$L  !24 0 :              "  3%? 0!E83$T
M.3,U,&5X-"TR7W-G8FQO8VMS+FAT;5!+ 0(4 Q0    ( "N$6E-!95QK7@D
M /,G   :              "  7VJ 0!E83$T.3,U,&5X-2TQ7W-G8FQO8VMS
M+FAT;5!+ 0(4 Q0    ( "N$6E,4%*4 8@L  &$H   ;              "
M 1.T 0!E83$T.3,U,&5X.3DM,5]S9V)L;V-K<RYH=&U02P$"% ,4    "  K
MA%I3[Z T$C(#  #M"P  $0              @ &NOP$ <V=B>"TR,#(Q,3 R
M-2YX<V102P$"% ,4    "  KA%I359 P?/T*  " A@  %0
M@ $/PP$ <V=B>"TR,#(Q,3 R-5]L86(N>&UL4$L! A0#%     @ *X1:4Z\=
M=JQ4!P  U5<  !4              ( !/\X! '-G8G@M,C R,3$P,C5?<')E
:+GAM;%!+!08     "@ * +X"  #&U0$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
